<p><table border="0" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">pert_id</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">pert_name</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">molecular_formula</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">chemical_formula</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">short description MOA</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">long description MOA</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">illnesses</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">pert_url</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">Pubchem cid</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">Pubchem url</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">DrugBank url</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">FDA</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">Tool</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">rank</th>
      <th style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;color: #305496;text-align: center;border-bottom: 2px solid #305496;padding: 0px 20px 0px 0px">reason</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A02481876</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">importazole</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C20H22N4</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Importazole is a selective inhibitor of importin-β transport receptors; somehow disrupts the importin/RAN interaction. Compounds are imported into, but not out of, cells.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Importazole has been used:\n• to inhibit importin-β and to elucidate the mechanism of enhanced nuclear localization of heat shock protein 70 (HSP70) by vaccinia-related kinase 3 (VRK3)[1]\n• to treat COS?7 cells transfected with the expressing vectors of WT HNF4α , S78A, and S78D to study its effect[2]\n• as a KPNB inhibitor to determine whether CREB-regulated co-activator 1 (CRTC1) would be escorted into the nucleus by the classical nuclear localizing sequence (NLS)- dependent machinery[3]\n• as a functional inhibitor of Importin β in embryo treatment[4]\n• as an importin inhibitor to treat the transfected H1299 cells to block nuclear translocation of phosphorylated p53-RS[5]</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.sigmaaldrich.com/catalog/product/sigma/sml0341?lang=en&region=US>http://www.sigmaaldrich.com/catalog/product/sigma/sml0341?lang=en&region=US</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">2949965</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/2949965>https://pubchem.ncbi.nlm.nih.gov/compound/2949965</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">11 (L1000FWD); 20 (TopoCMap)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A04308630</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">genipin</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C11H14O5</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Genipin is an excellent natural cross-linker for proteins, collagen, gelatin, and chitosan cross-linking; blocks the action of the enzyme uncoupling protein 2.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Genipin is a chemical compound found in Genipa americana fruit extract. It is an aglycone derived from an iridoid glycoside called geniposide which is also present in fruit of Gardenia jasminoides.[1]\n\nGenipin is an excellent natural cross-linker for proteins, collagen, gelatin, and chitosan cross-linking. It has a low acute toxicity, with LD50 i.v. 382 mg/kg in mice, therefore, much less toxic than glutaraldehyde and many other commonly used synthetic cross-linking reagents. Furthermore, genipin can be used as a regulating agent for drug delivery, as the raw material for gardenia blue pigment preparation, and as the intermediate for alkaloid syntheses.[2]\n\nIn vitro experiments have shown that genipin blocks the action of the enzyme uncoupling protein 2.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Genipin>http://en.wikipedia.org/wiki/Genipin</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">23340</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/23340>https://pubchem.ncbi.nlm.nih.gov/compound/23340</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">27 (L1000FWD); 31 (iLINCS)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools;  in PCA cluster</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A06935312</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">AC1Q5RFA</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C31H48O6</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Anti-HIV activity</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">3001077</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/3001077>https://pubchem.ncbi.nlm.nih.gov/compound/3001077</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">3.0</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A07395371</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">esmolol</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C16H25NO4</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Beta-1 adrenergic receptor\tantagonist</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Similar to other beta-blockers, esmolol blocks the agonistic effect of the sympathetic neurotransmitters by competing for receptor binding sites. Because it predominantly blocks the beta-1 receptors in cardiac tissue, it is said to be cardioselective. In general, so-called cardioselective beta-blockers are relatively cardioselective; at lower doses they block beta-1 receptors only but begin to block beta-2 receptors as the dose increases. At therapeutic dosages, esmolol does not have intrinsic sympathomimetic activity (ISA) or membrane-stabilizing (quinidine-like) activity. Antiarrhythmic activity is due to blockade of adrenergic stimulation of cardiac pacemaker potentials. In the Vaughan Williams classification of antiarrhythmics, beta-blockers are considered to be class II agents.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used for the short-term control of ventricular rate and heart rate in various types of tachycardia, including perioperative tachycardia and hypertension.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/104769>https://pubchem.ncbi.nlm.nih.gov/compound/104769</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">104769</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/104769>https://pubchem.ncbi.nlm.nih.gov/compound/104769</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00187>https://go.drugbank.com/drugs/DB00187</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">CLUE</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">35</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster 1 and UMAP cluster 1; FDA approved; in top 10 CLUE</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A14966924</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Alaproclate</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C13H18ClNO2</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">selective serotonin reuptake inhibitor (SSRI), hepatotoxic; it has also been found to act as a non-competitive NMDA receptor antagonist, similar to phencyclidine.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Alaproclate was developed as one of the first selective serotonin reuptake inhibitor (SSRI) antidepressants by Astra AB (now AstraZeneca) in the 1970s. Development was discontinued due to concerns over hepatotoxicity observed in animal studies. Alaproclate has also been found to act as a non-competitive NMDA receptor antagonist although without discriminative stimulus properties similar to phencyclidine.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Alaproclate was developed as one of the first selective serotonin reuptake inhibitor (SSRI) antidepressants by Astra AB (now AstraZeneca) in the 1970s. Development was discontinued due to concerns over hepatotoxicity observed in animal studies. Alaproclate has also been found to act as a non-competitive NMDA receptor antagonist although without discriminative stimulus properties similar to phencyclidine.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Alaproclate>http://en.wikipedia.org/wiki/Alaproclate</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">11957454</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/11957454>https://pubchem.ncbi.nlm.nih.gov/compound/11957454</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB13233>https://go.drugbank.com/drugs/DB13233</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">17</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; In top 10 iLINCS</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A15079084</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">phorbol-12-myristate-13-acetate</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C36H56O8</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Potent tumor promoter; activates protein kinase C in vivo and in vitro.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Phorbol 12-myristate 13-acetate is a phorbol ester. It works as a tumor promoter and is involved in gene transcription, cell growth, differentiation, programmed cell death, immune pathway and receptor desensitization via protein kinase C (PKC) signaling pathways. Phorbol 12-myristate 13-acetate is also a model agent to study growth factors-, hormones-, and cytokines-mediated regulation of cellular growth and differentiation.[1]</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.sigmaaldrich.com/catalog/product/sigma/p8139?lang=en&region=US>http://www.sigmaaldrich.com/catalog/product/sigma/p8139?lang=en&region=US</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">4792</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/4792>https://pubchem.ncbi.nlm.nih.gov/compound/4792</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">18 (L1000FWD); 11 (TopoCMap)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A19500257</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">geldanamycin</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C29H40N2O9</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Geldanamycin is a natural existing HSP90 inhibitor</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Heat shock protein HSP 90-beta; Heat shock protein HSP 90-alpha; Endoplasmin inhibitor</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">experimental</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Geldanamycin,http://www.selleckchem.com/products/geldanamycin.html>http://en.wikipedia.org/wiki/Geldanamycin,http://www.selleckchem.com/products/geldanamycin.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">13017911</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/13017911>https://pubchem.ncbi.nlm.nih.gov/compound/13017911</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB02424>https://go.drugbank.com/drugs/DB02424</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">28</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 TopoCMap</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A20697603</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">thiostrepton</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C72H85N19O18S5</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">FOXM1 inhibitor, protein synthesis inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Thiostrepton is a natural cyclic oligopeptide antibiotic, derived from several strains of streptomycetes including Streptomyces azureus and Streptomyces laurentii. Thiostrepton is a natural product of the ribosomally synthesized and post-translationally modified peptide class.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Thiostrepton has been used in veterinary medicine in mastitis caused by gram-negative organisms and in dermatologic disorders.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Thiostrepton>http://en.wikipedia.org/wiki/Thiostrepton</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">16129995</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/16129995>https://pubchem.ncbi.nlm.nih.gov/compound/16129995</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB11467>https://go.drugbank.com/drugs/DB11467</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">29</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 L1000FWD</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A25004090</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">erastin</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C30H31ClN4O4</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMgAAADICAYAAACtWK6eAAAXzklEQVR4nO3de1xUdd4H8A+DXETzkpqXFEG8YhYJKCiaVlQqrGnirQXXXcU0w3VrF312y3IrsbK0bF+hZWEWz4Ko2W5e2cTUNEUhU9uEGe5imoIXEGjm8/wxQVL6c5g5www83/c/cjnne76D85lz5pzf74wLSUIIcUM6RzcghDOTgAihIAERQkECIoSCBEQIBQmIEAoSECEUJCBCKEhAhFCQgAihIAERQkECIoSCBEQIBQmIEAoSECEUJCBCKEhAhFCQgAihIAERQkECIoSCBEQIBQmIEAoSECEUJCBCKEhAhFCQgAihIAERQkECIoSCBEQIBQmIEAoSECEUJCBCKEhAhFCQgAihIAERQkECIoSCBEQIBQmIEAoSECEUJCBCKEhAhFCQgAihIAERQkECIoSCBEQIBQmIEAoSECEUJCBCKEhAhFCQgAihIAERQkECIoSCBEQIBQmIEAoSECEUJCBCKEhAhFCQgAihIAERQkECIoSCBEQIBQmIEAotHN2AaDouX76MDRs24MqVKwgPD0dAQICjW7I72YOIWzpx4gSefPJJ3HnnnVi+fDn27duHYcOGYd26dY5uze4kIOKGqqurkZqaivDwcNx999347rvv8N5772Hfvn1ITk7G2rVrERcXh5iYGFRUVDi6XbuRgIh6zpw5g+XLl6N3796YPXs2evXqhW+++QbPPvssNm3aBD8/P2zduhWPP/44jhw5gqNHj2L48OHIyclxdOt2IQERdebMmQNvb29s2rQJS5cuxenTpxEYGIipU6ciPDwcRqMR//73vzF16lQAQP/+/XHw4EH0798fgwcPRmpqqoMfgR1QCJJJSUns168fDx8+zG+//Zbx8fFs374977zzTi5ZsoRnz55Vrp+YmEgPDw/GxcWxurq6kbq2PzmLJQAAer0evXv3xuDBg+Hr64uBAwciKSkJ48aNg0536wON2NhYBAYGIioqCkePHsU///lPdOvWrRE6ty85xBIAAIPBAF9fX+h0Opw8eRKfffYZIiMjLQpHrcDAQHz11VcwmUx488037dht45GACADmPYivry8AoFWrVlbVWLZsGfbv349HHnkE2dnZWrbnMBIQAcC8B+nVq5dNNTZu3IjS0lJNajkLCYjAtWvXcObMGZuf1LV7oev3Rk2dBETAYDDAZDLZ9KQuKytDWVkZevXqJQERzYvBYECnTp1w2223WV0jNzcXrq6u6NKlC4qLi+UQSzQfer3e5ie0wWBA9+7dUVJSYvPeyJlIQES9N9Xbtm0DyQbXqA2ZXq/H7bffjnbt2mncpWNIQASKi4vRokULlJSUIDo6GuPHj8fFixcbVKM2ZM3pDBZgh/kgNazBn4r+BCONMMGEMW3GoNJUiXYt2uGRNo9ovTmhgSeeeAIPPfQQfH19kZmZialTpyIgIAApKSkYOnSoRTX0ej1GjhzZ7AKi+Visd75/h+vPr6/7vspUxeQfkrmtfJvWmxIaysjIYNeuXTl69GgWFhYyPj6enp6eXLlypUXrX7hwgRcvXuTEiRO5aNEiO3fbeDQ/xDpx7QSCWwXXfe/u4q71JoQdjBw5EllZWXB1dUVISAgiIyOxbt06/O1vf0N0dDSuXr2qXF+v1yM+Ph6HDx9GRkYGzp0710id25fmARnoORCZFZl131ezWutNCDu54447sH37dsyaNQv3338/CgoKcPDgQWRmZiI0NBR5eXn1lq+oqMB7772HoKAghIaG4sKFC3j99dfh5uaGwYMH4+jBg455IFrSepdUbarmvPx5nJs/l/Py5/GTi5/YfIhVXFzM48ePs6amRsNOmzej0cjg4GCeOnXKqvW3bt3K9u3bc/z48SwqKuLTTz/N8vJykuTp06cZHx/PDh06sEuXLoyPj2d+fn7dujU1NVzy17+y0NubfOMNq7Z/8uRJJicn86uvvrJqfa00+nyQvKo8i5YzmUxMT0/npEmT2KJFCw4cOJAjRoxgcXGxnTtsHgoLCwmAJSUlVtfIz8/nkCFD2KdPHx47doy7du1iREQEXVxcOHz4cKakpKjnfmzeTLZtS8bGWrbB6moe+eQT3n///dTpdAwNDaW7uztXrVpl9WOwVaMGJOdaDj0yPfjymZdpoumGy5SXlzMxMZGDBg2ih4cHo6KiuGvXLp47d44PP/wwO3XqxJ07dzZm201SRkYGW7ZsSZPpxn9nS1VWVnLWrFns3r0727Rpw7i4uIbtlXJyyIwM9TJFReSSJWS3bvxh2DAuXLiQ//3vf0n+vCd79NFHefHiRasfh7UafQ+yrXwbO2Z15Ny1c3nhwoW6n588eZJxcXFs3bo1/fz8mJCQwJKSEqampnL06NE8dOgQTSYTExIS6O7uziVLltBoNDZ2+03G+++/T39/f01qFRcXEwC/++472wpVV5NPPknGxZHR0eTnn5t/vnw5GRhIJiaSV678arW8vDwGBwezb9++zM7Otq2HBnLIlNuCCwUcOnQofX19+fLLL3PYsGHU6XSMjIzkZ599xsLCQi5ZsoTdunVj+/btuXDhwnrHuOnp6ezcuTPHjRvHH374wREPwek999xzjIiI0KTWvn376OnpafsLUmIiuf6nSwA//kg+8MDPX99CZWUl4+Li6OnpyXfffde2PhrAYXPSq6qq+Nhjj3HAgAFctGgRDQYDjxw5wujoaLq5uXHw4MFMTEzklRu8opDmY+zQ0FB6e3vz4MGDjdy984uOjmZcXJwmtdavX8/+/fvbXuipp8jrD8+mTyevO4qwtBcvLy9GR0ezoqLC9p5uwWFDTdzd3TFo0CD4+vrihRdeQGRkJMLCwqDT6fDFF18gMzMTsbGxN53d1r17d+zduxfTpk3Dfffdh1WrVjXyI3BuWg45v3BhFEaPXm97IX9/IPOnSwAmE3D2LNC+fYNKREdH48iRI8jMzMTw4cORm5tre18qdo+gwowZMzh//nyS5KZNm3j+/Hmr6iQnJ7NVq1ZMSkrSsr0mrWvXrtyyZYsmtWbMML91sFl1NTlvnnlPEh1NpqdbXaq8vJwTJ07knDlzNGjs5hwakBEjRnDFihU21di7dy8NBgMXLlzIhx56SKPOGs/1p7Nnz57NzMxMm2tWVlbSxcWFX3/9tQYdkiNHkq+9pkkpTZlMJlZVVdl1Gw4dzavFPISFCxdi+/btKCsrg5+fn0ad2V95eTneeustDBw4EOPGjYOXlxcqKiowfPhwrFmzxqbaBoMBJDU7xNLrAWccf+ji4gJ3dzsPZbJr/BQqKyup0+mYlZVlU5327dtzx44dHDVqFF955RWNurOfG53OPnfuXN3vk5OT2aOHD+fOPc+rV63bxsqVK9mhQweNOibz8sjLlzUr16Q4LCCnTp0igLrhC9YoKyurOz/v7e3NjRs3atihdqqqqpiSksIHH3yQOp2ODz74IFNSUvjjTU5vnjxZRX9/8q67yG+/tWwblZWV/OCDDzhkyBC6urqyQ4cOjImJ4VVrU0bzhfC+fc1vHQwG8umnrS7VZDnsEEuv16Njx45o06aN1TVyc3Oh0+mceh50QUEBfHx8MH/+fAQHB0Ov12PXrl2IioqCq6vrDdcZMMAdhw4BgwYBy5ap6+fmAosWASEhwOLFf8Xo0aORm5uL/fv34+jRowgMDMSJEyes7j8kBLDxiK9Jc9itR7WYWKPX69GjRw+UlpbCaDQ65Tzol156CUFBQUhNTYWHh4fF67VuDXz8MVBVZf5+yxYgPh745huguBhYvRq44w5g8WIgLAxYvNgTEybkw93959B9+eWXiI2NRWhoKNauXYspU6Y0uP/wcGD7duC++xq8arPgsD3I9QGprKy0qsb192Fy1nnQer0eoaGhDQrH9a5f7Zev5o8+CmRnAxkZwJQpqBcOAGjdujU+/vhjvPbaa4iJicGcOXNQXa2eflBaChw+XP9nf/oT8PrrVrVvVlMDzJ8PLFgAxMQAe/bYUKxxOfQQq2fPnnVP8k2bNjW4Rm3InPk+TFr2Fh4OfPklcOWK+fu+fYG77rr1erGxsThw4AB27dqF4cOH/2peBwBkZJgwdSrQsyfw6qv1fzd4sPk5DgDkz19b7P33gaFDgVWrzF+/+GIDCziOwwISFhaGlJQUVFRUYOnSpZg2bZpFr3DXq73hsrPOgzYagZ49X0Hv3oM1q2ntq3lgYCAOHz6MTp06ITg4GDt27MDly5exZs0a3HPPPXj22TS0aAF8/jmQkmJe59FHgd/+1vz1hx8Cr70G/OMfwKhRQFGRYmNVVcBHH5kDAZiPC4N/mmXq6gp07gw08KYQjuKwgMybNw/h4eEIDg6Gq6tr3StcWFgY8vPzLaoxY8YMjB071mkDUlgIfP75Y/Dx6atZzetfzRuqQ4cO+Ne//oW4uDj85je/QdeuXbFs2TJMnz4daWmjsGEDMGyYusbUqUDbtuY+du/+sd7v8vLyoF++HOjRw5zk2mm6GgwxcRhHn0ZLSkqqG3xWVFTEMWPGsGPHjtyxY8ct1zUajdy6dSsDAgL4pCZjIbSVnk7edps2tYxG89QKCwa+WmTUqFGcOXMmS0pKeLmBFzmMRnLpUhMHDZrJpUuXcs+ePYyIiKBOp+OLkyeTH31Enj1LrlpFpqZqOsSksTk8ICR57Ngx9u7dm/feey9zcnKYkJDAFi1aMD4+/oZDrM+ePctly5bRx8eHt912GydOnMiWLVvyiSee4LVr1xzwCG7s3XfJu+/WplZ+PgmQpaXa1Ovfvz/Xr1/PyZMn85lnnrGqxq5du9ipUyfeddddnDlzJrOysnjs2DGe//OfyVatSD8/csMGbRp2EKcICGkefBYVFcU2bdowLS2NO3fupI+PD3NycuqWOXLkCGNjY9myZUv269ePCQkJdZOujh07xn79+nF/VJT5qpaVzp8/r9n4HoNBuxfLzz83P+dsnCBI0jyGydPTk/v27WNwcDDffvttq2sVFhZyyJAh/Mtf/sLQ0FC6urpy87x55LZt5l1NE+c0ASHN/3ErV66ku7s74+LiePXqVVZWVjIpKYkBAQF0d3evm4J7o6mkNWVl5IQJ5O23k59+avF2y8vLuXr1ag4cOJB9+/ZlUFAQDTaEzB5XoNetM19Z10JxcQVHjvxfFhd/z3vvncxt23bZVM/f35/jxo3j4sWLmZdn2T0HmgqnCkitvXv3slu3bgwJCWHbtm3Zo0cP/v3vf+eZM2duvbLJZB56+tJLt17266/JuXN5KDycvr6+TEhIYG5uLqOioti2bVumpaVZ1f/mzWRMDLl6tXYBef31bM6dm3PrBS2wdy/p6UmWl5sP2ywdznIjJpOJXl5ezLjVvPMmyikDQpKlpaX8+OOPuXnz5puOWbLIzeZBv/ACqdORY8aw5rPP6r3X+eWerKGf2rp5M/nhh+Tjj5PHj2sTkMcff5wLFiywvRDJpCRywADy2DHzn6Cy0vpaJSUlBMDCwkJNenM2Tvspt507d8a0adNsL1R7kSo62nxh4uGHzSfyp083n+Tv1etX421cXFywYMECBAYGYsqUKcjOzkZycjK6du2q3FRBAeDt/fP3tdcsbr/d9oeh1+sRHBx86wUtqmUevn75svlP4+lpfS2DwQAPD49m8Ym2N9L87+5+s4tUvXvfcpJDWFgYsrKy4O7ujoCAAKSnp/9qGZMJ2LYNiIwEfH1/Pt0P2HbN4npGoxG5ubmaXeuZPh147jlgxAjgwAHbaun1evj4+DTo03Cbkub5qK5n40WqTp06Ydu2bZg7dy7Gjh2L559/HiaTCefPn8err76KiIg/YPJkoFs34OhRIDDwxlegr10DxowBbpCxm/r++++xbNky+Pn5wd/fHyEhIZavfANbtgD9+pmDfMcdwDPP2FQOgLZDaZySo4/x7E7Di1RpaWls164dR44cSU9PTw4YMIBvvvkWLZnS8uOP5nujubub/1WdrlWdzraFPU4e/O53v+O8efNsL+SknPY9iGbc3IC339aolBvc3NwwZcoUFBUV4eDBgxbPZ3F1BZ5/3ryHSUjYjxMn3sS7765B27ZtAZg/aTYlJQVvvPEGTp48ifHjx2Pr1q144IEH4OLiokn/gPbD1w0GAyIiIrQp5oSaf0A0pNfr0adPH/j7++Ps2bNWfehlZCRwzz09MHlyPoKCgrBixQocOHAAa9euhYeHB2JiYvDpp5+ie/fudngEZlqfPHDGcXBakYA0QO3o4donhbWv7N7e3sjIyMCCBQuwfPlyeHl54Z133sGECRPQooX9/0u0Onlw+fJllJSUwMfHx/ZiTsqFtOITG/+f2v3UU7jm7Y0zNTXYn5WFD2rHhdvAaDTedOptYzh3zjzZ6o03gHvusWydvLw8vPPOO1i3bh28vLwQEBCApKSkusPF5qT5n8XS0IN79iCiY0fMPnECH9x5pyY1HRkOAGjTxjz3PSQEWLv25suZTCbs3r0bkydPRp8+fbB79268+OKL2LlzJ0pLSxEUFITs7OzGa7yRSEAaIi/PfO3EYDCfK20GPDzM85oSE4GPPkrBjBkzUFFRUff7srIyrFq1Cn369EFkZCQ8PT1x+PBhHDlyBDNmzMCaNWuwefNmjB07FiEhIVirSllT5OjTaE3GmTPmgUsFBWTnzg0aDNlUnDp1iv7+/gwICODGjRsZExNTdzr7rbfeYllZWb3lv//+ew4bNoze3t48dOgQP/zwQ7Zq1YrR0dE23W7ImUhALHX5MpmcTNbUkLNm2TSk3pmVl5czPDycPXv2ZERExE1HTteqqalhfHw83dzcmJCQUC9kp0+fbsTO7UMCYombDXhsplasWMERI0bw0qVL9e76qLJlyxa2a9eOEyZMYFFREadMmcI2bdowNTXVzt3al5zFssSaNUDLlvUHPO7e7eiu7Oapp57CpUuXMGLECKxevRpZWVkWrXf69GlMmjQJVVVVSE1NRXp6OuLj47FhwwZERUXZt2k7kTfplmjCd+WwRu34qobeDKNPnz748ssvMXToUAwbNgzh4eGYP38+Vq9ebcdu7UsCYommfFcOK1x/v7GGXiX38vJCUlISUlJS4O/vD6PRCO/r5wA0MXIl3RJ/+APwxz8Chw4BZWXA//yPozuyG5LIy8urC0hYWJhVdcaMGQPAvDcKCAjQsMPGJQGxhIYDHp3dmTNnUFlZWTekxtah7Hq9HhMmTNCou8Ynh1iiHr1eD09PT7Ru3Rrnz5+3eSBifn5+kx7MKAER9RgMBvj4+CAvLw8uLi42DUQsLS3FlStXJCCi+ah9Y24wGNCtWzd42jBh3WAwwN3dvUnPV5eAiHpqh/S3a9cOv62dN2yl2vnqjh6QaQsJiKhn0KBB2L9/P/z8/JCQkGBVjas/3bS6OcxXl4CIembNmgVfX1/ce++92L59u8XrkUR6ejomTZqEHj164MqVK0571/2GkICIetq2bYu0tDQ8++yzGD9+PBYtWgSj0XjT5S9duoQ1a9bg7rvvxrhx46DT6ZCSkoKCggIcP368ye9BZLCiuKk9e/awS5cuHD16NEt/cVv5o0ePMjY2lq1atar7OOuSkhKmpKRw1KhR1Ol0nDBhgoM6147sQcRN3XfffcjOzoaLiwuCgoJw4Ke7zP3nP/9BcHAwSktLkZaWhoyMDADA0KFDMXv2bPTt2xfHjx+36mP1nI6jEyqc3y/nfNTU1DA/P59ffPEFo6Ki6ObmxsDAQCYmJjabiVK1ZLi7sNimTZvw+9//HkOGDEFBQQEKCgowdepUzJ07V7P7BjsbCYhokJycHGzZsgUuLi6YOXMmbtfi5lpOTAIihIK8SRdCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIo/B9N1RnqjS677QAAAABJRU5ErkJggg==" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Erastin is a cell-permeable piperazinyl-quinazolinone; interacts with antiporter system Xc-</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Erastin is an antitumor agent selective for tumor cells bearing oncogenic RAS (i.e. HRAS, KRAS). Erastin produces ferroptosis, a non-apoptotic tumor cell death, by altering mitochondrial voltage-dependent anion channel (VDAC) gating allowing cations to enter mitochondria and leading to release of oxidative species causing oxidative cell death.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.sigmaaldrich.com/catalog/product/sigma/e7781?lang=en&region=US>http://www.sigmaaldrich.com/catalog/product/sigma/e7781?lang=en&region=US</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">11214940</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/11214940>https://pubchem.ncbi.nlm.nih.gov/compound/11214940</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">21</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 TopoCMap</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A30437061</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">camptothecin</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C20H16N2O4</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">topoisomerase inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Camptothecin (Camptohecine, 20-(S)-Camptothecin, CPT, NSC100880) is a specific inhibitor of DNA topoisomerase I (Topo I) with IC50 of 0.68 μM.\nCamptothecin demonstrated strong anticancer activity in preliminary clinical trials but also low solubility and adverse drug reaction. Camptothecin is believed to be a potent topoisomerase inhibitor that interferes with the essential function of topoisomerase in DNA replication.\n\nCamptothecin binds to the topoisomerase I and DNA complex resulting in a ternary complex, stabilizing it and preventing DNA re-ligation and therefore causes DNA damage which results in apoptosis.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Investigated for the treatment of cancer.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Camptothecin,http://www.selleckchem.com/products/Camptothecine.html>http://en.wikipedia.org/wiki/Camptothecin,http://www.selleckchem.com/products/Camptothecine.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">2538</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/2538>https://pubchem.ncbi.nlm.nih.gov/compound/2538</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB04690>https://go.drugbank.com/drugs/DB04690</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">33</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 L1000FWD</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A34006693</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Suprofen</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C14H12O3S</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMgAAADICAYAAACtWK6eAAAW9UlEQVR4nO3deVSU59kG8Es2xRlZIkkEXAIuIBpxCVUpRqMY2+qJMRYrJrjXWOOWmhaPn5W01lRbk6Px2H5mkYhbQmrctxhjTMRalyiuMyoIIuCGrAIyzFzfH/MxOlEfUWZh9P6d43HeZ8a57zly8c48877P24AkIYS4JzdnNyBEfSYBEUJBAiKEggRECAUJiBAKEhAhFCQgQihIQIRQkIAIoSABEUJBAiKEggRECAUJiBAKEhAhFCQgQihIQIRQkIAIoSABEUJBAiKEggRECAUJiBAKEhAhFCQgQihIQIRQkIAIoSABEUJBAiKEggRECAUJiBAKEhAhFCQgQihIQIRQkIAIoSABEUJBAiKEggRECAUJiBAKEhAhFCQgQihIQIRQkIAIoSABEUJBAiKEggRECAUJiBAKEhAhFCQgQihIQIRQkIAIoSABEUJBAiKEggRECAUJiBAKEhAhFCQgQihIQIRQkIAIoSABEUJBAiKEggRECAUJiBAKEhAhFDyc3YBwIQYD8PbbgLs7UFgIjB0L9Onj7K7sqgFJOrsJ4SI++gjw9gYSEgCjERgwAPjmG2d3ZVfyFkvU3smTQFSU+ba7O/Dss+Y9yWNMAiJqLyICOHLEfNtkAq5cAfz9nduTnclbLFF7BgMwfbp571FUBIweDfTt6+Sm7EsCImonORkICjJ/7niCyFss8WAmE5CUBOTn3x67etV5/TiQBEQ82I4d5g/jv/61eZsEevYEVq92bl8OIAGpJ6qqqnD69Gl89913qKqqcnY71pYvB4YPB7Ra8/aePea9ycCBzu3LAeQziIMVFhZCp9PhzJkz0Ov10Ol00Ol0yMzMRHV1NVq0aAE/Pz+kpaWhSZMmzm4XKCgAgoOB774DevQwj73+OuDmBqxc6dTWHEECYid5eXk4ffo0MjMzcerUKcvtCxcuwMPDAy1atEBoaCgiIiLQoUMHREREoFOnTvD09MSLL76I4OBgfPXVV3Bzc/JO/oMPgI8/Bs6cMW8XF5s/rG/d+th/iw5IQOosPT0dZ86csewJ9Ho99Ho9Kioq4O/vj/DwcLRv3x5hYWEIDw9HeHg4QkND4eFx/6N8Ll68iBdeeAGTJk3Cu+++67gXcy+RkcDIkcCMGebtf/4TWLgQyMgAGjRwbm8OIAGpg+XLl2P27NkAgA4dOljtEUJDQxESEoIGj/hDtG/fPsTGxmLlypWIi4uzZdu1d+AA0KsXkJMDNGtmHuvWDXjtNeB//sc5PTkaxSMxGo1s2bIlP/nkE5s8n06nY1xcHCsqKixjixcvplar5YkTJ2xS42GtnzWLuZMm3R5ITyfd3cmLF53SjzNIQB7Rtm3bqNVqWVJSYpPnKy4uZkREBBMSEqzGx48fz5CQEF6/ft0mdWqrrKyMPj4+3Lp1q2Ws8p13yF/9yqF9OJsE5BENHTqU48ePt2zn5+ezvLy8Ts+p0+no6+vLRYsWWcYqKyvZvXt39u/fn9XV1XV6/oeRnJzM4OBgS82Kigo+ExDAtE2bHNZDfSABeQTXr19nw4YNuX//fsvY66+/znHjxtX5uTdu3EhPT0/u2LHDMpaXl8fg4GDOnDmzzs9fWzExMZw1a5Zle+3atQwICGBlZaXDeqgPJCCP4P3332dYWBhNJhNJsqioiI0bN+aePXts8vzvvvsun3rqKWZkZFjG9u/fz4YNG3Lt2rU2qaGi1+vp5ubGc+fOWcZiY2M5Y8YMu9eub+ptQG7cuMHc3Fxnt3FPnTp14sKFCy3bS5cuZUhIiCUwdWUymRgXF8fIyEiWlZVZxj/77DN6e3vz8OHDNqlzP4mJiezTp49l+8KFC3Rzc+OpU6fsWrc+qrcBmThxIl944YU6v6+3tQMHDtDDw4P5+fmWsa5du3LevHk2rVNaWsqOHTvytddeswrexIkT2apVK169etWm9WoYDAYGBQVx5cqVlrE5c+awZ8+edqlX39XbgJSUlDAiIoJvvPGGs1ux8tvf/pZDhgyxbKenp9Pd3Z0X7TD1mZmZyYCAAM6fP98yVlVVxd69ezMmJoZVVVU2r7lx40b6+vry5s2bJM3T2a1ateLHH39s81quoN4GhDTP6vj5+fGDDz5wdiskyfLycvr5+XHLli2WscmTJ/NXdpz6/Prrr+nl5WVV8/Lly2zRogWnTZtm83pbt25lUlIST58+TZLcsWMHNRoNi4uLbV7LFdTrgJDm/yBPT09u377d2a0wOTmZzZo1o8FgIEneunWLAQEBXLdunV3rLliwgD4+PpYfWpL88ccf2bhx40f+otJoNDIjI4Pbtm3j+++/zwkTJvDFF1/k008/TQAMDg7mwIEDmZCQwDFjxtjqpbiceh8Qkpw7dy6feuopnj9/3ql99OrVy2lTn/Hx8QwLC2NRUZFlbOXKlWzUqBH/+9//3vff3bp1iydPnmRqairnz5/PhIQEduvWjRqNhgDo5+fHbt26MS4ujklJSUxNTeXhw4d58eJFNm/enFOnTuWVK1fs/vrqK5c4Foskhg8fDp1Oh/3790Oj0Ti8h7Nnz6J9+/bQ6/Vo06YNAKB///6IjIzEwoUL7V6/oqLinkf5/v73v8fnn3+O3bt3o7y83HLkcM3fWVlZMJlMCAwMvOfxYqGhofet+eOPPyImJgZLly7FmDFj7P4a6yUnB7TWSktL+fzzz3PIkCE2m059GImJiezdu7dlu2bq8+TJkw7rITs7m8888wyTkpIsYwaDgdHR0dRqtfTy8mJERATj4uKYmJjIFStW8PDhw1ZTxQ8rJSWFjRo14sGDB23wClyPywSENP9QBgQE2HxK9UFqpj5TUlIsY3PmzGGPHj0c2gdJ7tmzh9OnT7+rtyVLltjtF8fUqVMZFBRUb7+XsieXCghJ7tq1i15eXty8ebPDam7atKneTn3+tDd7MBgMfOmllxgdHc1bt27ZrU595HIBIcl//OMfbNKkicO+2R08eDAnTpxo2d65c2e9mfr8aW/2UlBQwNDQUE668/D3J4BLBoQkx4wZc9esjj1cvnyZnp6eVu/Bhw0bVi+mPu/Vmz0dO3aMGo2Gy5Ytc0i9+sBlA1JRUcGoqCgOGDDAroeBL1iwgB07drRs1xzJ+8MPP9itZm39tDdHWLduHb28vPj99987tK6zuGxAyNuzOn/6059s+rzFxcU8ePAgU1JSGBISwgULFlju0+v1HDt2rFNm0n6qffv2VueOOEpiYiKbNWvGnJwch9d2NJf4HkQlLS0N/fr1Q0pKCoYNG/ZQ//bixYuWpXfuXIYnLy8PHh4eCA0Nhbe3N1q2bImNGzc+8vnl9pCWloa+ffvi0qVLePrppx1a22Qy4ZVXXkF+fj727dsHb29vh9Z3JJcPCAAsXboUM2fOxP79+/H8889b3WcwGJCTk2O19M6pU6dw/PhxlJaWomHDhmjdurVl6Z07v0zz9vZGdnY2oqKi8NZbbyEpKclJr/BuY8eORVlZGVJTU51Sv7CwEN27d0ePHj2QkpLilB4c4bEICACMHz8eu3fvxvTp05GTk2PZI2RlZcFoNKJly5aWpXfuXIYnKCjogc+9b98+9OvXD6tXr8ava5bfdKKysjIEBQXhyy+/xAAnLiat0+nQo0cPzJ07F1OmTHFaH3blzPd3tlReXs42bdqwXbt2jIuL4+zZs7lmzRoeOXKkTt8k11i0aBG1Wq1Dvzm/n08++YTNmzd36Dnq97NhwwZ6eXnx22+/dXYrdvHYBMQRh2WPGzeObdu2ZWFhod1q1EbPnj05Z84cp/Zwp6SkJDZt2tTqFOHHxWPzFmvYsGHQarVYvny53WpUVlaiT58+8PHxwfbt2+Hu7m63Wvej1+sRERGBs2fPonXr1g6vfy8kMWzYMJw7dw5paWnQaDSoqKhAZWUlKioqUFhYiMLCwkfavnnzJq5cuQJn/Zg+FgEpKChAcHAwdu/ejZ///Od2rZWfn4+oqCgkJCTgb3/7m11r3cs777yDY8eO4Zt6dvHM0tJS9OjRA5cuXUJJScld9/v4+ECj0UCr1cLHxwe+vr6W7SZNmsDX1xdardbyx8/PD1qtFsePH8e8efOQn58Pbc3q8o7kzN2XrSxatIjt2rVz2HcTjlxh5E4Gg4HNmjXjmjVrHFq3tiIjIzlt2jQePnyYer2eubm5dT7SwWAwMDAwkCtWrLBRlw/nsQhIZGQk//73vzu0pr1XGDEajbx27ZrV2FdffUU/P796t5AFaT7spUGDBtTpdDZ/7j/+8Y9Wq6w4ksu/xTp06BCio6Nx8eJFBAYGOrT27373O2zfvh2HDh165C/rqqqqcO7cubsulaDT6dCmTRscO3bM8thBgwYhJCQES5YssdErsJ3Vq1dj5syZyMnJsRqvrq5GaWkpioqKUFZWhps3b6KsrAyFhYWW2zdv3kRhYaHV/UVFRVi7di0CAgLuebKao7h8QCZOnIjLly9jw4YNDq9tMBjQv39/GI1GfPvtt/D09LzvYwsLC60C8LBn/F2+fBktWrTAwYMH0aVLF0e9xFobPXo03N3d8emnnwIARo0ahS+++AK3bt2yepyXlxc0Gg38/f2h1Wotn0NqPnPU/PH19cWbb74JPz8/AEB0dDT69euHuXPnOvaFOWW/ZSM1q4xscuJ6saoVRv7whz+we/fu9PX1JQA2btyYXbp0YXx8PP/85z/ziy++4LFjx6xWdL+fefPmsVOnTnZ4BbbRvHlzq89kJ06cYFpaGtPT05mRkcGCgoI6nUvy0UcfOeW7H5cOyIoVK9isWTO7rA/1MO63wsiHH37IxYsXc+fOnczKynroSQSTycTs7Gzu3LmTLVu25JIlS2zZts2cOnWKbm5udl3cobS0lFqt1mrNYkdw6YD07t3boQs6q6xateqBK4zcT2VlJdPT05mamsq//OUvjI+PZ9euXS0rj/j6+nLGjBl2P/flUS1atIhdu3a1e51Ro0bxN7/5jd3r3MllP4NkZmaibdu2OHXqFMLDw53dDoDbK4wcOnQIwcHBd93/088hNbf1ej2MRiP8/f3vOmCyQ4cOdbpSlSO8+upghIWFY8GCBXats3fvXrz88svIzc1FQECAXWvVcNmAzJo1C2lpadi7d6+zW7EwGo0YNGgQCgoKMHPmTGRkZECv11uuYXjjxg00atQIYWFhlj81B06GhYU5ZTmjuiKrcOhQMJo3T0VQ0Et2rkW0a9cO06ZNw+TJk+1aq4ZLBsRoNCIkJARz587FqFGjnN2OlYKCAkydOhVff/01IiIiLD/8Nbefe+4551+51oZKS/fi/PlfIDLyBtzc7H9eyF//+lesX78eR44csXstwEUDsmXLFsTHxzvv8ANhkZc3GzdvHkLbtjsdUi83NxetWrXC4cOH0blzZ7vXc8lfZcuXL8eIESMkHPVAScku+Pj0d1i94OBgxMbG4rPPPnNIPZcLyNWrV7FlyxaMGzfO2a088YzGIpSXH3FoQABgzJgxWLVq1V1fQtqDywUkJSUFYWFh+NnPfubsVp54JSW74eERAG/vTg6tO2TIEDRo0ACbNm2yey2XC0hycjJeeeUVfPjhh85u5YlXWroLTZrEAnDsFLSXlxeGDx+O5ORku9fysHuFOsrLy4NOp4Ner8eBAweQm5uLmJgYDBkyBM888wyGDx/u7BafWCUluxAYOMdh9YxGo+UktTFjxiAqKgo5OTlo0aKF/Yo69GvJ+7l1izx9mvmbN/O9997jyJEjGRUVRR8fHwKgVqtlt27dOHz4cB49epSk+WI2jrigpbg3k8nA/PwFrKrKf/CDbeDy5cuMiYmxunZi586d7b6Qed3eYm3YANTMJly6BEyeDBgM5r+nTQNGjgS+++7242/cAP7zH2D5ciAxERg8GAgLAzQaICICmgUL8M0330Cj0SAhIQH//ve/kZ2djdLSUsTGxgIAIiMjAZiPHh01ahSGDh2Ka9eu1elliNorLz+GjIyhyMmZjgYNGsDTs5ndax49ehTdu3eHm5sbXn75Zcv46NGjkZycbN/TcesUr/XryeRk8+2cHPKtt8hly8iaywRUV5P9+t1+fEwM6elJhoaSsbHk1Knmx//wA/mAxRYyMzPZtGlTq1UOay5o2bdvX8tl0YR95ee/x+Jixx0wuGbNGjZu3JgTJkywOii1sLCQ/fv35y9/+Uu7nkla94D06UO++Sb5xhvmgEyZQp45c/sxI0aQN26Yb1+7RtbhB7nmgpZbt261jNUcbn7nNTOE/VRX3+ClS4m8cGEkr179lx3rVDMxMZGNGjXip59+anWfXq9n+/bt2aVLF2ZlZdmtB9IWAfnpHuRf/yJXrTKPGY3WexAbmD9/Pv39/Xn27FnL2MGDB9moUSPu+/xzm9YSajrdiySNNn/egoICxsbGMjg4mAcOHLC6b+vWrfT19eWIESMccuqx7QNSVUVOmmTekyQkkLt317nJO5lMJsbHxzM8PNzq8O+zqalk48bkoUM2rSes3bjxJbOzJzE7exJzct62jBsM123y/Onp6QwNDWV0dDTz829PAJhMJs6fP59eXl5W1423t/oxi/WQysvL2a1bNw4ePJhG4x2/waZPJwMDySfwUmHOZDBc5dGjPrx0KZFG44PPjryf1NRUajQaTpgwwersw9LSUg4dOpRNmzblrl27bNFyrblkQEjz9Qrju3Zl8R0f2lldTf7iF2R0tHnqWDhMaekPPHkyjCdOtGZJycMtQ6raO5w/f54dO3Zkp06dmJmZacuWa8VlA0LSPPvl5UV++eXtsYICsnVr0gGXJRPWjMZyXrqUyCNHPJiVNYHV1SUP/DclJSUcPHgwAwICuGfPHqv7duzYQX9/fw4bNswm6ys/CtcOCEkuXkxqteSdi0qnp5MaDfm//+u8vp5gZWX/4cmTETx+/DkWF++87+NUs1HLli2jl5cXk5KSnHqxItcPCEmOG0e2bUveuaj0unXmvcvevU5r60lmMlUyN3c2jxzx4ooVibxRM9X//yoqKhgUFMSRI0darepSUVHBkSNH0sfHhxs2bHB023d5PAJSUUF2707272/+HFJj3jybz6KJh3P9+nF27dqVgYGBXL9+vdV9d07Vk2ROTg6joqLYrl07nj592oFd3t/jERCSzMsjg4PJerLKibjNYDBw0aJF1Gg0HDRoEHPvMcv4/fff89lnn+XAgQPr1eotj09ASHLfPrJhQ/IJuQKrqzl//jxfeukl+vn5WV1KuubzRmJiovW0fT3gkuekKx09CnTuDFRXA2+/Dbi7A4WFwNixQJ8+zu7uiWcymbB06VLMmjULvXr1go+PD7Zt24aUlBS8+uqrzm7vLo9fQGp89BHg7Q0kJABGIzBgAFDPrqnxJMvKysKUKVPg7u6O9957DxEREc5u6Z7q/QlTj+zkSWDSJPNtd3fg2WfNexJ/f+f2JQAAzz33HDZv3uzsNh7I5U65rbWICKBm7SSTCbhyRcIhHtrj+xbLYACmTzfvPYqKgNGjgb59ndyUcDWPb0CEsIHH9y2WEDYgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRQkIEIoSECEUJCACKEgARFCQQIihIIERAgFCYgQChIQIRT+D2tlmswH8pAsAAAAAElFTkSuQmCC" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">is an NSAID, inhibits prostaglandin synthesis; binds to the cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) isoenzymes, preventing the synthesis of prostaglandins and reducing the inflammatory response</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Suprofen is a non-steroidal anti-inflammatory analgesic and antipyretic. Ophthalmic anti-inflammatory medicines are used in the eye to lessen problems that can occur during or after some kinds of eye surgery. Sometimes, the pupil of the eye gets smaller during an operation (pupil constriction), making it more difficult for the surgeon to reach some areas of the eye. Suprofen is used to help prevent this.\n\nSuprofen binds to the cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) isoenzymes, preventing the synthesis of prostaglandins and reducing the inflammatory response. Cyclooxygenase catalyses the formation of prostaglandins and thromboxane from arachidonic acid (itself derived from the cellular phospholipid bilayer by phospholipase A2). Prostaglandins act (among other things) as messenger molecules in the process of inflammation. The overall result is a reduction in pain and inflammation in the eyes and the prevention of pupil constriction during surgery. Normally trauma to the anterior segment of the eye (especially the iris) increases endogenous prostaglandin synthesis which leads to constriction of the iris sphincter.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Used as eye drops to inhibit the miosis (pupil constriction) that may occur during ocular surgery.\n\nAn ibuprofen-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic. It is no longer approved for use in the United States.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Suprofen>http://en.wikipedia.org/wiki/Suprofen</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">5359</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5359>https://pubchem.ncbi.nlm.nih.gov/compound/5359</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00870>https://go.drugbank.com/drugs/DB00870</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">20.0</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved; In top 10 iLINCS</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A36151937</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">genistein</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C21H20O10</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">tyrosine kinase inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Genistein, a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM.\n\nGenistein may inhibit cancer cell growth by blocking enzymes required for cell growth.\n\nGenistein may decrease cardiovascular risk in postmenopausal women by interacting with the nuclear estrogen receptors to alter the transcription of cell specific genes. In randomized clinical trials, genistein was seen to increase the ratio of nitric oxide to endothelin and improved flow-mediated endothelium dependent vasodilation in healthy postmenopausal women. In addition, genistein may have beneficial effects on glucose metabolism by inhibiting islet tyrosine kinase activity as well as insulin release dependent on glucose and sulfonylurea</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Currently Genistein is being studied in clinical trials as a treatment for prostate cancer.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Genistein,http://www.selleckchem.com/products/Genistein.html>http://en.wikipedia.org/wiki/Genistein,http://www.selleckchem.com/products/Genistein.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">5284639</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5284639>https://pubchem.ncbi.nlm.nih.gov/compound/5284639</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB01645>https://go.drugbank.com/drugs/DB01645</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">24</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 L1000FWD</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A48237631</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">mitomycin-c</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C15H18N4O5</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">It is an alkylating agent that inhibits DNA synthesis (at high concentrations, RNA and protein synthesis) by cross-linking the complementary strands of the DNA double helix.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Mitomycin is activated in vivo to a bifunctional and trifunctional alkylating agent. Binding to DNA leads to cross-linking and inhibition of DNA synthesis and function. Mitomycin is cell cycle phase-nonspecific.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used as an adjunct to ab externo (outside approach) eye surgeries for the treatment of glaucoma and used as a chemotherapeutic agent for various malignancies.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.scbt.com/datasheet-3514-mitomycin-c.html,http://www.selleckchem.com/datasheet/Mitomycin-C-DataSheet.html>http://www.scbt.com/datasheet-3514-mitomycin-c.html,http://www.selleckchem.com/datasheet/Mitomycin-C-DataSheet.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">5702003</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5702003>https://pubchem.ncbi.nlm.nih.gov/compound/5702003</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00305>https://go.drugbank.com/drugs/DB00305</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">9 (L1000FWD); 29 (TopoCMap)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A71390734</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">idarubicin</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C26H27NO9</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">topoisomerase inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Idarubicin HCl (Idamycin, Zavedos, 4-demethoxydaunorubicin) is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL.\n\nIdarubicin is an antineoplastic in the anthracycline class. General properties of drugs in this class include: interaction with DNA in a variety of different ways including intercalation (squeezing between the base pairs), DNA strand breakage and inhibition with the enzyme topoisomerase II. Most of these compounds have been isolated from natural sources and antibiotics. However, they lack the specificity of the antimicrobial antibiotics and thus produce significant toxicity. The anthracyclines are among the most important antitumor drugs available. Doxorubicin is widely used for the treatment of several solid tumors while daunorubicin and idarubicin are used exclusively for the treatment of leukemia. Idarubicin may also inhibit polymerase activity, affect regulation of gene expression, and produce free radical damage to DNA. Idarubicin possesses an antitumor effect against a wide spectrum of tumors, either grafted or spontaneous. The anthracyclines are cell cycle-nonspecific.\n\nIdarubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Idarubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">\nFor the treatment of acute myeloid leukemia (AML) in adults.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Idarubicin,http://www.selleckchem.com/products/Idarubicin.html>http://en.wikipedia.org/wiki/Idarubicin,http://www.selleckchem.com/products/Idarubicin.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">42594</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/42594>https://pubchem.ncbi.nlm.nih.gov/compound/42594</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB01177>https://go.drugbank.com/drugs/DB01177</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">20</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">f</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A77216878</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">manumycin-a</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C31H38N2O7</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Antibiotic that acts as a selective and vigorous inhibitor of Ras farnesyltransferase</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Manumycin A is an antibiotic originally generated by Streptomyces parvulus that acts as a selective and vigorous inhibitor of Ras farnesyltransferase. The compound has been observed to block the activity of IKKβ by robustly and rapidly inhibiting TNF alpha induced phosphorylation of IκBα and NF-κB nuclear translocation. Studies indicate that Manumycin A has the ability to induce the dimerization of IKKβ and dissociation of IKK from IKKγ/NEMO, the adapter protein. Atherosclerosis studies report that Manumycin A decreases oxidative stress. Additionally, Manumycin A irreversibly inhibits neutral sphingomyelina, and has been shown to produce nitric oxide and induce apoptosis in leukemia cell studies. Manumycin A is an inhibitor of Farnesyl Transferase and N-SMase.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.scbt.com/datasheet-200857-manumycin-a.html>http://www.scbt.com/datasheet-200857-manumycin-a.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">73707404</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/73707404>https://pubchem.ncbi.nlm.nih.gov/compound/73707404</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">28 (L1000FWD); 14 (TopoCMap)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A78322124</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">dobutamine</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C18H23NO3</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Beta-1/2 adrenergic receptors agonist; Alpha-1 adrenergic receptors agonist; Estrogen receptor alpha</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Dobutamine is a direct-acting inotropic agent whose primary activity results from stimulation of the beta-adrenoceptors of the heart while producing comparatively mild chronotropic, hypertensive, arrhythmogenic, and vasodilative effects. Dobutamine acts primarily on beta-1 adrenergic receptors, with negligible effects on beta-2 or alpha receptors. It does not cause the release of endogenous norepinephrine, as does dopamine. Dobutamine directly stimulates beta-1 receptors of the heart to increase myocardial contractility and stroke volume, resulting in increased cardiac output.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used to treat cardiac decompensation in patients with organic heart disease or from cardiac surgery.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/65324>https://pubchem.ncbi.nlm.nih.gov/compound/65324</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">65324</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/65324>https://pubchem.ncbi.nlm.nih.gov/compound/65324</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00841>https://go.drugbank.com/drugs/DB00841</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">CLUE</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">34</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster 1 and UMAP cluster 1; FDA approved; in top 10 CLUE</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-A82371568</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">clofarabine</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C10H11ClFN5O3</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMgAAADICAYAAACtWK6eAAAV1klEQVR4nO3de1SUdf4H8DdyHYhRQARmwMy85YUCL2Hl5aSmKWoy6maJZptUlNRqZ632Au6ePbrbaY+X9pTh5o52tI1G8FKBSKtp2cqieNSfq5ZAwgiK3OQit/n8/nh20OHyBZ3L88zweZ3jYa7P9wPOe77f55lnvl83IiIwxjrVR+4CGFMyDghjAhwQxgQ4IIwJcEAYE+CAMCbAAWFMgAPCmAAHhDEBDghjAhwQxgQ4IIwJcEAYE+CAMCbAAWFMgAPCmAAHhDEBDghjAhwQxgQ4IIwJcEAYE+CAMCbAAWFMgAPCmAAHhDEBDghjAhwQxgQ4IIwJcEAYE+CAMCbAAWFMgAPCmAAHhDEBDghjAhwQxgQ4IIwJcEAYE+CAMCbAAWFMgAPCmAAHhDEBDghjAhwQxgQ4IIwJcEAYE+CAMCbAAWFMgAPCmAAHhDEBDghjAhwQxgQ85C7AVpqpGauLV6OVWmGCCU+rn0aDqQH9PPphlnqW3OUxJ+UyAfmk/BNM8J2A+KB4AEATNWFP5R6Zq2LOzmWGWOduncN4v/Ft173cvGSshrkKlwnIKJ9RyKvPa7veRE0yVsNchRsRkdxF2EIzNePNK2+CQHCDG2aqZ6LeVM/7IMwqLhMQxuzBZYZYd3qn5B0kFCXIXQZzAS4ZkPv63IeipiK5y2AuwCUDovHSwNhslLsM5gJcMiBaTy1KmkrkLoO5AJcMiMZTg8rWSjSYGuQuhTk5lwyI1ksLADzMYlZzyYAEuAdA1UeFkmYeZjHruGRAAGmYZWziHoRZx2UDMsRjCMpry+Uugzk5lw1IwLoAFGwqkLsM5uRcNiAajQZGIw+xmHVcOiAlJbyTzqzjsgHRarXcgzCruWxAeIjFbMFlA6LVatHQ0ICKigq5S2FOzGW+k96eRqMBABiNRgQGBspcDWtqakJubi5u3ryJiIgIaDQaBAQEyF1Wt1w2ICqVCgEBASgpKcHo0aPlLqfXS0hIwJkzZ1BYWNjWq/v6+raFJTw8HFqtFn8YOBCeGg0QFgaEhwOhoUCfTgY6zc3Ar34FuLsDlZXAiy8CU6cCGRlAVRXwwgtAcTGwYQPwwQf3XLfLBqSoqAharRZbtmxBREQERo4cKXdJvdbnn3+Of/7zn/j3v/+NyMhINDQ0oLi4GEajEVeuXIHRaERJSQkuXbwIj2+/BYqKgNJSoLUV8PAAQkKAgQOl0Dz2GLBmDbB9O/Doo0B8vPS4mTOlgNiYSwYkLS0NCQkJiI6ORmtrKyIjI/HUU09hzZo1mDZtmtzl9So//fQTVq5ciS1btiAyMhKA1LsPHToUQ4cO7fqJra1SSIqLAaNR+nnnYfuzZ4HEROmyu7sUospK6bpeD/zwA1BXB/Tta90vQC6kvr6ekpKSyMfHhzZu3Egmk4mIiC5dukRJSUnk6+tLkZGRtHXrVmpoaJC5WtfX1NREMTExpNPpbL/xDz8k+vRT6XJrK9G0adLl9HSi7duly1euEL32mlXNuExAzp49S6NHj6aHHnqI8vPzO33MtWvXKCUlhQYMGEAajYbWr/8L3bjh4EJ7kbfeeosiIiLohj3+yE1NRImJRKtWEcXHE+XkSLdzQCyZTCbauHEjeXt7U3x8PNXW1rbdV19fT+Xl5R2e09DQQKmpqaTTfUJ+ftLf8NIlR1bt+jIzM8nLy4u+++47uUuxilMHpKyM6MUXT9GAAQMoPT29w/16vZ58fX0pMTGRLl682Ok2jh4lio0lcneXfmZn27noXqCsrIxCQ0PpT3/6k9ylWM1pA5KVRRQaSjRlCtGVK7VdPu7o0aMUGxtL7u7uFBsbS9ldJOD0aaKEBCIfH6LoaCK9nqi52U7FuzCTyURz5syhKVOmUEtLi9zlWM3pAtLcTJScTOTlJf3s6f/B6dOn6YUXXiBvb28aN24cGQxlnQbAaCR65x2iwECiSZOk29LTiYYNk4a9BQVEa9bY5ndxRX/+858pODiYSkpK5C7FJpwqIAUFRBMnEg0cKA2N7oXRaKSUlPcoJETaznvvEVVVdXxcbS3RqVPS5fR0omXLiD74gAMikpubS15eXrR37165S7EZpzkXa8cOYMwYQKMB8vOBJ564t+2EhYUhOfktFBUBf/wj8Mkn0ge2L78MXLx4+3F+fsAjj9y+PmMGcPw4UFtrzW/humpra/H8888jMTER8+bNk7scm3GKgJSWAm+/DWzaBHzxBWCLU3i8vYFly6TPmz79FLhwARg5EtiypevnrF4N/PWv1rftil555RV4e3tj/fr1cpdiU4oLSEYGMHy4dKpNYSHw1lvS6TiXL0un29hanz7A/PnA4cPSh68zZ3b92OhoqS5mafv27cjIyMDnn38OHx8fucuxKUWeahITA3z8MTBnzu3bHPF3Hzeu89ufeUb6WV0NbNsm9T5M8uOPP+KNN97A3/72N4wYMULucmxOcT0IoNzxfkQEcOyY3FUoR2NjIxYvXoynn34ay5cvl7scu1BkDwLcHu8r6ascWq103pzT6OqUcBtZu3YtqqurkZqaarNtKo1iA6LE8b5G42QB6eqUcKMRuHpV+NSzbm5oFKytlJeXhw8//BBHjhyBWq22ceHKobiAmMf7585JR65GjZK1HAtO14N0dUr4xx8D69YJnxo3aBAuFRZ2eb9Go8Hy5csRExNjw4KVR5H7IIB0SHfzZrmrsKTRWH4lQfFGjgTy/rewqckElJVJx8hTUgAi4b+LBQUg6YPkTv+9+uqrOHfunKy/niMoNiDtX4zZ2cCQIfLVAzjhEOuXvwS+/x5ISpK+gvruuzbb9KJFi3D8+HEUFxfbbJtKpLghlln7F2NAAFBQALS0SN/ClINW62Q9SHU18LvfSR8k2djw4cMxYsQI7N27F6+99prNt68Uiu1B2r8YNZrbowS5aDTSvq3JJF8Nd2XrViAuzm6bj4uLw549e+y2fSVQbEA0GuD6daCpSboeEiL1HHK+g2s0LRgx4jtcv+4kK1d98QWg09lt8zqdDkeOHMH169ft1obcFBsQrVbaXywtla6bD8LIuQ+g0RDOnZsMo/G/8hXRU5cvA6dPAwsW2K2JqKgo3H///di3b5/d2pCbYgMSHAx4eVn2GHLvA3h6eqJ///7OMaVpWhowdiwweLBdm1mwYIFLD7MUGxA3N2nf8s7XohKOIjnNrPEGg12HV2Y6nQ7Z2dmoNE+542IUGxAAmDLlHGpq/q/t+vDhm1FR8baMFTnJrPFXrgD/+Y9dh1dmMTExCAkJwVdffWX3tuSg6IDU1yfjwoUdbdfV6lr89NNJGStyklnj09KAyEjpewN25ubmhvnz57vsMEvRAWn/YlTCi9MphlgOGl6Z6XQ6ZGZmoq6uzmFtOoriA3Lni1Gr1Tr0xXnt2jXMmTMHBw8etKhB7pCKGI1GxFdVoWbhQoe1OXnyZPj5+SEzM9NhbTqKogPS/sWo0WhQVVXlkHeqnJwcREVFob6+3mLia6X3IAaDAbmtrVA/9JDD2nR3d8e8efNccpil6IB01oMAwNVuTtW2RktLC1JSUjB79mysXLkShw4dQnh4OADAZDLh6NGj6NevH3bt2mW3GqxhMBiwePFih7er0+mwf/9+3Lp1y+Ft25WMM6p06/z58wSAampq2m7z8/Ojw4cP26W9y5cv08SJE2ngwIF0tN28QlevXqUZM2ZQcHAwrVq1ilQqFa1YscJiqlO5lZaWkru7e5dzE9tTU1MTBQQE0IEDBxzetj0pvgcBYDHMOnLkCMZ19eVxK+zYsQORkZHQaDTIz8/HE3fMK5Sdnd22lMKpU6ewefNm5OXl4eTJkxg7dixOnTpl83ruRXp6OgYPHoyHH37Y4W17enpi9uzZrjfMkjuh3fH396esrCy7bb+6upqWLl1KKpWKNm7caHHfrVu3aO3ateTl5UXJycnU2tpqcX9DQ0PbcgsbNmzocL+jTZ8+nd5++23Z2t+zZw8FBQVRswvN2arYgJhnbddqtRQaGkrr16+niooKm7Zx4sQJGjJkCEVHR9OFCxcs7jt//jxFRUXRoEGDup2hPD09nQIDA2nGjBl09epVm9bYU+Xl5eTh4UG5ubmytE8kzabv5+dHhw4dkq0GW1NkQK5du0axsbHUt29f2rFjB+n1eho1ahT5+flRQkICnT9/3qrt37lkQlJSEt26dcvifr1eT35+frRo0SKqrKzs0TaLiopo0qRJNHv2hbalKhxp27ZtNGjQoLZFg+Si0+koMTFR1hpsSXEBycnJIY1GQzExMXT58uW2200mE2VnZ/dopnaR0tJSmjlzJgUHB3fYoayurqYlS5aQv78/7dix46633dzcSr//PZGnJ9G779p/dviWlhb65ptv6PXXX6dhw4bRhAkT7LNYTQ+1trZSfHw8jRo1il599VXKyclx+hneFROQ5uZmSk5Obhvvi/6w+fn5lJCQQD4+PhQdHU16vb5H496MjAwKCgqi6dOnk9FotLjvhx9+oMGDB9O4cePokpWr6Rw+TBQeTjR+PNGPP1q1qQ4aGxvp66+/ppdeeomCg4NJpVLRggULaOPGjTRx4kSKiIigI0eO2LbRHigpKaEnn3ySBgwYQOvWrSOdTke+vr7Uv39/eumllygzM5OampocXpe1FBGQixcv0bhx43o03r9TaWkpJScnU1BQEIWFhVFycrJwP2XdunX0/vvvWwxDWlpaaMOGDeTl5UVJSUnU2Nho1e9iVlVFtGgRkVpNtGuXdduqryfav/9bWrp0KfXr14/UajUtWbKE0tLSLA4zm99kPDw8KCkpyWEvyKysLAoNDaVp06ZZLHtQV1dHaWlp9Oyzz5K/vz8FBATQ8uXL6duvviJqN6xVKtkDotcTRUefpCVLnu/xeL+9hoYG0uv1NGLECPL396ekpCQqLCzs9nk///wzTZ48mUJCQujrr7++p7a7o9cT+fpKy+jdzUcmNTVEu3dLIfPzI5o58++0YsUK2r9/f4d9pva++eYb0mq19Oijj1oMU23NfBTP09Oz06N87R+bkZFB8fHxlDNrlvTO8dxzRAaD9A6gULIFpKaGaOlSIpWKqN3R1XvW2tpK+/bto+nTp7ftp3z//fedPnbPnj0UGBhITz31lN2PPOXnE40ZQ9TdAaaKCilQ5lD07y8Fa98+orvt2K5fv952oOOzzz679+K7cP78eXrkkUfogQce6PJv3KWWFmmBl6QkopAQ6UUQGyv98tXVNq/VGrIE5MQJoiFDiEaPJjpzxj5t5OXlUXx8PHl4eNDYsWNJr9dTS0uLxWcXdy4VbW/mN9fOVqsymYhmzyby8CC6/36iN9+UXj/WfqzSfoHTuro6K38LifkoX3x8PN28edO6jTU3Ex08SPTyy0QDBkhhee456b6mJmmF1aQk6Z3iX/+SbrfxSrYiDg2IyST1Ft7e0u/siGFoYWEhrV69mtRqNT344IP04IMPCpeKtreuVqvatk3qYeyRV/MS2SNHjqTTp0/f83aqqqro2WefJbVaTTt37rRhhf/T0iKFIDVVur51K5H5aGJLi93WQhdxWEBKS4lmzSIKDiaS43Sd6upqeuONNygwMJCqZezG09OJdu4kev55qfd01HJu9fX1Fj3n3Tp+/Dg98MADNH78eKuP8vXYqlVEd37m9dxz0jg0PZ1o6lSp11m61K4BuetzsTIygH/8Q7pcXAy8/jrw5ZfAypXSvLp793a+CE5ZmTQJw5kzlut+OIparcb69evR2NiI3NxcxxfQjqNXq1KpVNi0aRN27tyJlJQUxMXFoaKiotvnmc9unjRpEubOnYtjx45hiKOmuOxq6lQAWL4c+OgjwM4rWtnkZMU5c4DUVGDXLmD3buk28yI4ZpGRUnhCQmzR4r1RqVSYNWsWDAaDfEX8j1yz1y9cuBD5+fkoKytDVFQUjgkWPPn555/x5JNP4qOPPsKBAwewadMmeHl5Oa5YO06d2mN32+WIere1a4mOHZNvGNETu3btopCQENlOLLx6leizz+yzr3E3uvtg1mAwUGBgIM2fP5/Ky8tlqlJ+9xSQzvaPfvMboi+/vP2YnTuJ8vKIVqxQVkBqamrIx8eHjh07Jkv7mzcTDR8uS9OdOnToEIWFhdHUqVOpuLi4w76K3Od2yc0m00B//DGwfz9QXg7897+35ypT4iI4/v7+mD59OgwGAx5//HGHt28wAL/4hcOb7dK0adNw6tQpLFu2DA8//DDUajV8fX1x4sQJjBkzRu7yZOdGJFhGyEVt374d69atQ0FBAdzc3BzWblmZNDvkyZPSPpmSEBGWLFkCo9GIrKwsqFQquUtSBEV/o9Be5s2bh5KSEpw86dg5ttLTpd5VaeEApPmthg4diqCgIA7HHXplQIKCgrBixV9w6NB9Dm3XYAAcOBvPXeuFg4lu9cqAAEBU1K/w97/bf+ZBsxs3gMOHHTqf2z1x5JDTGfTagMTFSSsEnD3rmPYyMoDwcOnAhVJxD9JRrw1ISAgwcSLgqEk4vvyyFnFx0qz1SsY9iKVeGxBA6kUc8aF6VVUVsrJCsHixsleF5R6ko14dkIULpXPDLl60bzv79u1DQEAAJkwY2f2DZcY9iKVeHZCICGkRpowM+7ZjMBiwcOFCfvE5IcUuA+0o5mHWr3/d+f2pqdJaiZ3x9PwCzc2dnxE7d+5chIWF4ebNmzh48KDFDPFKFf7KK3Azr5rKAHBAoNNJp8rU1gL3dfKxSGpq18s+BwTsR2Vl5/sV48ePR1hYGA4cOIC+ffviscces2HV9mFyd0dLn149qOig1wdk2DCgoKDr+0+cED1b3+32DQYDdDod3N3d77o2R+Nd9I56/dtFZ1/uspX6+npkZmZCp/RPB+/Ae0mWen0PAtz+cted33TMzQWqqzs+1s0N6NfPfPksiBq73G5OTg5UKhUmT55s24LthHuQjjggAGbMADIzgSlTbt/2299KITFrbATq6y2fp9W+jJKS74Xb3r17Nzw8nOfPzD2IJef5n7Mz83fEAwOl61lZPXnWd/YsyfH4g8IOev0+iJkSv9wlB+5BLPX6HuSZZ25f3rlTtjIUwbtPH/g4wdE2R+qV3yhkrKd6fQ/CJIerqrD72jXc7+ODSD8/xAYFyV2SInBAWJvYoCDM5WBY4ICwNgdu3MCZujo8HRiIqM7Ou+mFOCCsDfcgHfFhXsYE+CgWYwLcgzAmwAFhTIADwpgAB4QxAQ4IYwIcEMYEOCCMCXBAGBPggDAmwAFhTIADwpgAB4QxAQ4IYwIcEMYEOCCMCXBAGBPggDAmwAFhTIADwpgAB4QxAQ4IYwIcEMYEOCCMCXBAGBPggDAmwAFhTIADwpgAB4QxAQ4IYwIcEMYEOCCMCXBAGBPggDAmwAFhTIADwpgAB4QxAQ4IYwIcEMYEOCCMCXBAGBPggDAmwAFhTIADwpgAB4QxAQ4IYwIcEMYEOCCMCXBAGBPggDAmwAFhTIADwpjA/wPU9nB4qQ17SwAAAABJRU5ErkJggg==" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Clofarabine inhibits the enzymatic activities of ribonucleotide reductase and DNA polymerase</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Clofarabine is metabolized intracellularly to the active 5'-monophosphate metabolite by deoxycytidine kinase and 5'-triphosphate metabolite by mono- and di-phospho-kinases. This metabolite inhibits DNA synthesis through an inhibitory action on ribonucleotide reductase, and by terminating DNA chain elongation and inhibiting repair through competitive inhibition of DNA polymerases. This leads to the depletion of the intracellular deoxynucleotide triphosphate pool and the self-potentiation of clofarabine triphosphate incorporation into DNA, thereby intensifying the effectiveness of DNA synthesis inhibition. The affinity of clofarabine triphosphate for these enzymes is similar to or greater than that of deoxyadenosine triphosphate. In preclinical models, clofarabine has demonstrated the ability to inhibit DNA repair by incorporation into the DNA chain during the repair process. Clofarabine 5'-triphosphate also disrupts the integrity of mitochondrial membrane, leading to the release of the pro-apoptotic mitochondrial proteins, cytochrome C and apoptosis-inducing factor, leading to programmed cell death.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used to treat relapsed or refractory acute lymphoblastic leukemia in patients 1 to 21 years old.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Clofarabine,http://www.selleckchem.com/products/Clofarabine.html>http://en.wikipedia.org/wiki/Clofarabine,http://www.selleckchem.com/products/Clofarabine.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">354624</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/354624>https://pubchem.ncbi.nlm.nih.gov/compound/354624</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00631>https://go.drugbank.com/drugs/DB00631</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">31</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 TopoCMap</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K01976263</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">emetine</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C3H6ClNO2</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">protein synthesis inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">protein synthesis inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Emetine is a drug used as both an anti-protozoal and to induce vomiting.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Emetine>http://en.wikipedia.org/wiki/Emetine</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">11957493</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/11957493>https://pubchem.ncbi.nlm.nih.gov/compound/11957493</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">22</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 L1000FWD</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K05901394</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">terguride</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C20H28N4O</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">a serotonin receptor antagonist; investigated as a PAH treatment</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">a serotonin receptor antagonist, is also being investigated as a PAH treatment, as serotonin has been implicated in proliferation of arterial smooth muscle cells</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">experimental</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/11957722>https://pubchem.ncbi.nlm.nih.gov/compound/11957722</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">11957722</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/11957722>https://pubchem.ncbi.nlm.nih.gov/compound/11957722</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB13399>https://go.drugbank.com/drugs/DB13399</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">CLUE</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">50</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster 1 and UMAP cluster 1; In top 10 CLUE</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K06593056</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">LE-135</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C29H30N2O2</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">LE 135 results in increased activity of RARG protein</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">10410894</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/10410894>https://pubchem.ncbi.nlm.nih.gov/compound/10410894</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">14 (L1000FWD); 24 (TopoCMap)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K07303502</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">arachidonyl-trifluoro-methane</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C21H31F3O</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">putative specific cytosolic phospholipase A2 inhibitor;Cytosolic phospholipase inhibitor\tPLA2G4A</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">The goal of this study was to determine the effects of a putative specific cytosolic phospholipase A2 inhibitor, arachidonyl trifluoromethyl ketone (AACOCF3), on arachidonic acid (AA) release and lipid mediator biosynthesis by ionophore-stimulated human neutrophils. Initial studies indicated that AACOCF3 at concentrations 0-10 micro m did not affect AA release from neutrophils. In contrast, AACOCF3 potently inhibited leukotriene B4 formation by ionophore-stimulated neutrophils (IC50 approximately 2.5 micro m). Likewise, AACOCF3 significantly inhibited the biosynthesis of platelet activating factor. In cell-free assay systems, 10 micro m AACOCF3 inhibited 5-lipoxygenase and CoA-independent transacylase activities. [3H]AA labeling studies indicated that the specific activities of cell-associated AA mimicked that of leukotriene B4 and PtdCho/PtdIns, while the specific activities of AA released into the supernatant fluid closely mimicked that of PtdEtn. Taken together, these data argue for the existence of segregated pools of arachidonate in human neutrophils. One pool of AA is linked to lipid mediator biosynthesis while another pool provides free AA that is released from cells. Additionally, the data suggest that AACOCF3 is also an inhibitor of CoA-independent transacylase and 5-lipoxygenase. Thus, caution should be exercised in using AACOCF3 as an inhibitor of cytosolic phospholipase A2 in whole cell assays because of the complexity of AA metabolism</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5280436>https://pubchem.ncbi.nlm.nih.gov/compound/5280436</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">5280436</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5280436>https://pubchem.ncbi.nlm.nih.gov/compound/5280436</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; CLUE</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">38 (L1000FWD); 15 (CLUE)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster 1 and UMAP cluster 1; Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K07691486</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">roscovitine</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C19H26N6O</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">CDK inhibitor; preferentially inhibits CDK2, CDK7 and CDK9</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">R-roscovitine (Seliciclib or CYC202) is a cyclin-dependent kinase (CDK) inhibitor that preferentially inhibits multiple enzyme targets including CDK2, CDK7 and CDK9, which alter the growth phase of treated cells. Developed by Cyclacel, seliciclib is being researched for the treatment of non-small cell lung cancer (NSCLC), leukemia, HIV infection, herpes simplex infection, and the mechanisms of chronic inflammation disorders.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">is being researched for the treatment of non-small cell lung cancer (NSCLC), leukemia, HIV infection, herpes simplex infection, and the mechanisms of chronic inflammation disorders.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Seliciclib,http://www.sigmaaldrich.com/catalog/product/sigma/r7772?lang=en&region=US,http://www.selleckchem.com/products/Roscovitine.html>http://en.wikipedia.org/wiki/Seliciclib,http://www.sigmaaldrich.com/catalog/product/sigma/r7772?lang=en&region=US,http://www.selleckchem.com/products/Roscovitine.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">160355</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/160355>https://pubchem.ncbi.nlm.nih.gov/compound/160355</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB06195>https://go.drugbank.com/drugs/DB06195</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">7 (L1000FWD); 4 (TopoCMap)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K08547377</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">irinotecan</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C33H38N4O6</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Irinotecan prevents DNA from unwinding by inhibition of topoisomerase 1.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Irinotecan inhibits the action of topoisomerase I. Irinotecan prevents religation of the DNA strand by binding to topoisomerase I-DNA complex. The formation of this ternary complex interferes with the moving replication fork, which induces replication arrest and lethal double-stranded breaks in DNA. As a result, DNA damage is not efficiently repaired and apoptosis (programmed cell death) occurs.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used to treat metastatic carcinoma of the colon or rectum.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Irinotecan,http://www.selleckchem.com/products/Irinotecan-Hcl-Trihydrate-Campto.html>http://en.wikipedia.org/wiki/Irinotecan,http://www.selleckchem.com/products/Irinotecan-Hcl-Trihydrate-Campto.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">23581792</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/23581792>https://pubchem.ncbi.nlm.nih.gov/compound/23581792</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00762>https://go.drugbank.com/drugs/DB00762</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">6 (L1000FWD); 25 (TopoCMap)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K12762134</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">XAV 939</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C14H11F3N2OS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">inhibitor of tankyrase PARP</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">XAV-939 specifically inhibits tankyrase PARP activity. XAV-939 dramatically decreases DNA-PKcs protein levels, confirming the critical role of tankyrase poly-ADP-ribosylation activity in maintaining stability of the DNA-PKcs protein. The greatest reduction of DNA-PKcs protein levels (&lt; 25% relative expression compared to DMSO treated controls) occurs at 12 hours with 1.0 μM XAV-939 exposure. Treatment of human lymphoblasts with 1.0 μM XAV-939 results in marked elevation of tankyrase 1 levels. [1] XAV-939 is axin stabilizing agent. XAV-939 stimulates beta-catenin degradation by stabilizing axin, the concentration-limiting component of the destruction complex. XAV-939 stabilizes axin by blocking the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2. Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degradation through the ubiquitin-proteasome pathway. XAV-939 deregulates the Wnt/b-catenin pathway which has been implicated in many cancers.\nXAV-939 is a selective Wnt &amp;#946;-catenin-mediated transcription inhibitor for TNKS1 and TNKS2 with IC50 of 11 nM and 4 nM, respectively.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.selleckchem.com/products/XAV-939.html>http://www.selleckchem.com/products/XAV-939.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">2726824</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/2726824>https://pubchem.ncbi.nlm.nih.gov/compound/2726824</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">34.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K14550461</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">doxercalciferol</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C28H44O2</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">A synthetic vitamin D2 analog used to treat secondary hyperparathyroidism in patients with chronic kidney disease</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Calcitriol (1α,25-(OH)2D3) and 1α,25-(OH)2D2 regulate blood calcium at levels required for essential body functions. Specifically, the biologically active vitamin D metabolites control the intestinal absorption of dietary calcium, the tubular reabsorption of calcium by the kidney and, in conjunction with parathyroid hormone (PTH), the mobilization of calcium from the skeleton. They act directly on bone cells (osteoblasts) to stimulate skeletal growth, and on the parathyroid glands to suppress PTH (parathyroid hormone) synthesis and secretion. These functions are mediated by the interaction of these biologically active metabolites with specific receptor proteins in the various target tissues. In patients with chronic kidney disease (CKD), deficient production of biologically active vitamin D metabolites (due to lack of or insufficient 25-hydroxyvitamin D-1-alpha-hydroxylase activity) leads to secondary hyperparathyroidism, which contributes to the development of metabolic bone disease.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used to treat secondary hyperparathyroidism in patients with chronic kidney disease with or without therapy of dialysis.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Doxercalciferol>http://en.wikipedia.org/wiki/Doxercalciferol</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">73707407</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/73707407>https://pubchem.ncbi.nlm.nih.gov/compound/73707407</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB06410>https://go.drugbank.com/drugs/DB06410</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">34</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K15108141</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">gemcitabine</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C9H11F2N3O4</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Gemcitabine is a nucleoside metabolic inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Gemcitabine is a potent and specific deoxycytidine analog. After uptake into malignant cells, gemcitabine is phosphorylated by deoxycytidine kinase to form gemcitabine monophosphate, which is then converted to the active compounds, gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). These active metabolites are nucleosides that mediate antitumour effects. dFdCTP competes with deoxycytidine triphosphate (dCTP) for incorporation into DNA, thereby competitively inhibiting DNA chain elongation. The non-terminal position of dFdCTP in the DNA chain prevents detection of dFdCTP in the chain and repair by proof-reading 3′5′-exonuclease: this process is referred to as "masked DNA chain termination." Incorporation of dFdCTP into the DNA chain ultimately leads to chain termination, DNA fragmentation, and apoptotic cell death of malignant cells.2,3,4\n\nGemcitabine has self-potentiating pharmacological actions that can increase the probability of successful incorporation of gemcitabine triphosphate into the DNA chain: dFdCDP inhibits ribonucleotide reductase, an enzyme responsible for catalyzing the reactions that generate dCTP for DNA synthesis. Since dFdCDP reduces the levels of dCTP, there is less competition for gemcitabine triphosphate for incorporation into DNA.2,4 Gemcitabine can also reduce metabolism and elimination of active metabolites from the target ce1l, prolonging high intracellular concentrations of the active metabolites. Such self-potentiating effects are not present with cytarabine.2</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used to treat relapsed or refractory acute lymphoblastic leukemia in patients 1 to 21 years old.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Gemcitabine,http://www.selleckchem.com/products/Gemcitabine(Gemzar).html>http://en.wikipedia.org/wiki/Gemcitabine,http://www.selleckchem.com/products/Gemcitabine(Gemzar).html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">60749</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/60749>https://pubchem.ncbi.nlm.nih.gov/compound/60749</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00441>https://go.drugbank.com/drugs/DB00441</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">TopoCMap</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">33</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 TopoCMap</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K15164005</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">apoptosis-activator-II</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C15H9Cl2NO2</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMgAAADICAYAAACtWK6eAAAYyklEQVR4nO3deVRTZ/oH8AcMO8iibJZSEzYBZ6pWtJWjpYq79hxrGatVpzoVx6pox06p40+dM7aKZ9yq01NB7RGH2tF2tFKtUjqtPS644UaIG4tYXBETRGCIJN/fH5lEg3AlkOQm8fmck1Puhdz3Sc03z31vknudAIAYYy1yFrsAxmwZB4QxARwQxgRwQBgTwAFhTAAHhDEBHBDGBHBAGBPAAWFMAAeEMQEcEMYEcEAYE8ABYUwAB4QxARwQxgRwQBgTwAFhTAAHhDEBHBDGBHBAGBPAAWFMAAeEMQEcEMYEcEAYE8ABYUwAB4QxARwQxgRwQBgTwAFhTAAHhDEBHBDGBHBAGBPAAWFMAAeEMQEcEMYEcEAYE8ABYUwAB4QxARwQxgRwQBgTwAFhTAAHhDEBHBDGBHBAGBPAAWFMAAeEMQEcEMYEcEAYE8ABYUyAROwCLOrhQ6L33yfq1IlIqSSaPp0oKUnsqpgdcQIAsYuwmKwsIg8PoilTiDQaouHDiX78UeyqmB1x7F0suZwoIUH3c6dORMHBuk7CWBs5dkDi4ogKC3U/a7VEt28T+fuLWxOzK469i/XwIdH8+bruoVIRvfMO0eDBIhfF7IljB6Q5jYbo/Hmi2Fgid3exq2F2wLF3sYqKiP7v/x4tazRE/foRFReLVxOzK44dkJoaolWrdMEgInJ1JQoPJ7pyRdy6mN1w7IBERxM1NhJVVj5aFxXFAWFt5tgBCQoi8vU1DgQHhJnAsQNCRBQZyQFh7eb4AWkeCA4IM8GzGZDqaqJ798SridmNZyMgly8/Wu7eXXc0i7sIa4NnIyDl5URNTbpliYQoIoLUZWXi1sXsgsMHRBsdTYqXX6a7164Z1o2LjKRPLl4UsSpmLxw+IM4BATSwuJhOPbab1T0igq7wLhZrA4cPCBFRVFSUUSCaLzPWGg4IYwKe2YDU1NTQnTt3RKyK2YNnMiDh4eHk7u7OXYQ91TMTkKtXr5JarSYiImdnZ5JKpRwQ9lTPTEA0Gg2Vl5cb1kVHR3NA2FM9EwHx9fWloKAgQyC0Wi1P1FmbPBMBISJ6/fXXqaamhpKSkig8PJw8PDxo7dq1YpdloNVqaefOnbRjxw66x58Tsx14Rty6dQs9e/bEoEGDsG3bNkRERCAwMBAZGRn473//K1pdGo0G27dvR1xcHHx9fdGrVy+EhITg22+/Fa0m9sgzEZCbN28iLi4Ow4cPR319PQBArVYjMzMToaGheOGFF5CZmYmmpiar1aTRaLBz50706NEDPj4+SE9Px71796DRaJCZmQlPT0+kpKSgqqrKajUJefjwodgliMLhA1JRUYHIyEiMHDkSDQ0NT/y+rq4OGRkZ8Pf3R1xcHHbu3AmtVmuxevTBiImJQUBAAJYuXQqlUvnE3xUXF6Nfv34IDg7Grl27LFbP0+Tn56N///5ISEjAn/70J8MLjJjUWjXmXJuDWRWzMLNiJr5Vfouvqr/C/pr9Zh/LoQNy9epVyGQyjBkz5qm7Uffu3cNHH30Ef39/jB5diZ9/Nm8tajXwxRcaxMX1QdeuXbF8+XLcv39f8D5NTU3IyMiAm5sbUlJScPfuXfMWJSA/Px8JCQnw8vJCWloacnNz0aNHD8hkMhw8eNBqdbRk452N2HZ3m2G5UdvIATHVpUuXEBYWhpSUFKjV6jbf79atOsyZA7i6AsOGASdPdqyOxkYgMxPo3h0ICgI+//w4amtrTdqGtbqJVqtFbm4uXnrpJUMwbty4Yfh9fX090tPTIZFIkJqaigcPHlisFiFzr83FhYYLRus4ICa4cOECunXrhrfeeqvd+84VFUBqKiCRAMnJwLlzpt2/sRHIzgYiIoDAQCAjA6ira1cpAHRzAEt1E41Gg9zcXPTp0wfe3t5IS0vDzZs3W/37o0ePIiYmBhEREaJ0k413NiKnOsewzB3EBAqFAqGhoXj77bfNMum+cAFISQE6ddL9t6RE+O/1HSMsTNcxOhqM5uRyORISEhASEoLdu3d3aFv6YPTq1ctwoKC6urrFv713757RshjdpLCuEIBuDvJexXuYVTEL71W8hz3KPRyQtjhz5gy6du2KGTNmQKPRmHXbJ04AQ4cCbm7AtWvA7t1AdLRublFeDixYAFRXA926Ac8/D/zjH0ALxwTMoqPdpLUjaK3Jz89HQEAAcnJynvjd493kl19+MfmxtMVe1V70v9Afnqc9cUt9yyJjtMZhAnLq1Cl06dIFf/zjHy16FEq/q7V7NzB1qi4I+oAAwHff6bqINZjaTR4/gtalS5dWj6A1p9VqkZmZCR8fH4waNQqVlZVGv7dUN8mvyUe/C/3gVuiG1KupuK6+bpbtmsIyAVGrgdmzgbQ0YMoUGA4JVVbqXnbHjweWLAF27gQUCqCDx9hPnDgBf39/LNA/S61g927gn/8E3n4bKCp6FBBra95NWtpFUqvVyM7ORlRUFLp27YqlS5dCpVKZPFZ5eTkGDx4MPz8/ZGZmPvH7I0eOdLibaKFFrioXfRV94XXaC2nX0nBDfePpd7QQywQkMxPY9r/DcE1NwJAhup9VKt36Dz8ERo0CXngBINIdMnrxRWDiRNxfswZ79uxBaWlpmzrBoUOHDLsJ1qQPSGEhMG2aeAHRk8vl6Nu3r9G78I2NjcjOzkZkZCQCAwOxdOlS1NTUdGgcfTfx9vZuUzepa+METN/dRpwdAZ8zPlhYuRBVD8V/k9QyAZk7Vze71Zs0CWhtH7emBjh6FMjKAtLSUD5tGoKCgkBE8Pb2RkJCAqZPn47Vq1cjLy8P168/arMHDx6Et7e31cMBPAoIAEyeLH5AAF03WbZsGVxdXTFmzBg8//zzCA0Nxdq1a9v8RG2rtnST6Ojop3YT/Udt4uPj4evri1V7VqH6YcsHCsRgmYB8/jmgn9BpNI86iAmqqqrw008/YcOGDZg5cyYSExPh5+cHIkJqair2798PDw8P/O1vfzNz8fbv7NmzCA0NxaJFi1r89IC5PN5NRo8ebfTiBQh3E1MPFIjFcnOQ997TdZIpU4D//Ee3fvFiYOVKYN8+4OrVdm362rVr+OKLL+Dh4YE1a9aYsWjT/f73wFdfiVpCi1QqFYgIJU87Jm0mZWVleO21157aTSIjI3Hw4ME2fdTGVlj3KNYHHwBJSUCXLrq5R+fOwCuvADNmAJ9+Cvz4I6pv3xbcRF1dHQIDA7FhwwYrFd26kBDAFj90W15eDiIyOvybl5eHq+18UWqLp3WTBw8eYM6cOQgODkZAQECbPmpjC8Q7zHvzJpCfD6xdC7z7LtC/P7RdusBdIoG/vz8SExORmpqKdevWIT8/H7f/F5yKigq4uLjg8OHDopUOAFVVuoxb6UXaJKdPn4aTk5PRpwgiIiKwY8cOi4+t7yb+/v4tdhN/f3+7+ii/RLQvooSE6G7JyY/WAaS4epWKi4tJLpeTXC6n7OxsUigU1NjYSM8//zy98sorNHnyZFq2bBkdOHBAtPLlciJPTyKpVLQSWqVSqcjHx4ckkkf/vEqlkvz8/Cw+tlQqpR9//JE2bNhA77//PpWWltLKlSuJiAgA3b9/n7p162bxOsxFvIC0wMnJiaRSKUmlUhozZoxhfVNTE5WWllJRUZHhW4E9evSgI0eOUGJioii1yuVE8fFEzjb4nUylUkn+j13uGgDV1NQYrbMkZ2dnmjdvHo0ePZrq6+sN6+/fv08ajcZqdZiDTQWkNRKJhGJiYigmJsawbtKkSbRixQrau3evKDUVFxP17CnK0E/VPCC1tbWiPDEjIyONllUqFRGRXQXEBl//2mbx4sWUl5dHJ0+eFGV8fQexRc13p5RKJRGRVXaxhCiVSnJyciJfX19R6zCF3QYkMjKSJkyYQB9//LEo4ysUtttBVCqV0au0/olpCwHx9vY2mhvZOrsNCBHRokWLaN++fXTq1Cmrjnv9uu4CVbbcQR4PiEqlsoknZvPg2gO7DkhsbCy9+eabtHz5cquOe/HicRoyZCOFhVl12DZrHpDmy2KxlTpMYdcBISJasmQJ5ebm0rlz56w25tmzh6mx8UurjWcqlUr1xBzEFp6YtlKHKew+IHFxcTRu3Dj65JNPrDZmcXEx9bTVCQi13EHEnn8QPRlce2D3ASEi+utf/0q7du2ioqIiq4wnl8sp3lYnIPRkIGxl3587iEji4+Pp9ddft8pcRKvVkkKhsOkO0tJRLFt4YtpKHaZwiIAQ6eYiX3/9NcnlcouOU15eTnV1dTbdQZoHxFZ2bWxlV88UDhOQXr160ahRoygjI8Oi48jlcgoJCaHAwECLjtNe9fX11NjYaJMdxFZ29UzhMAEh0s1FduzYQZcuXbLYGHK53KZ3r1p619xWXrltJaimcKiA9OnTh4YNG0YrVqywyPabmpro9OnTdhkQW3hi2kpQTWE/7/m30ZIlSygxMZEWLVpEUVFR7dqGUqmk4uJiUigUVFZWZrgpFAry9fUlZ1v8CO//qFQq8vDwIHd3d6N1thAQW6nDFA4XkP79+9OQIUMoIyODtmzZ0urfKZVKKisreyIIFy9epLq6OnJzc6OIiAiKj48nmUxGycnJJJPJiIho/Pjx9Pnnn9OsWbOs9bDarKVusWPHDtEPKjQ0NDwxN7IHDhcQIt1c5NVXX6W5c+eSRqMxPPn1Ybh8+TLV1taSq6srhYWFUVxcHMXHxxtCIJPJSCqVkpOTU4vbz87OpgkTJlDPnj1p4MCBVn50wvQfCHzcoEGDrFpDXV0dbdy4kRISEgxj63f97C0gDnNmxeaSkpLg5OQEFxcXyGQyJCcnG32Ft7S0tEOnJ/3zn/+MkJCQJ757LbaqqioEBwfjd7/7He7cuWPVsWtra7Fy5UoEBgZCKpVi7969ht/J5XIQkUXPsmIJDhkQpVIJT09PbN++3Wzn6K2qqsLRo0cNy01NTRg+fDgGDBiARmuda7SNSktL8eqrryIoKAhff/21xcerra3FunXrEBISgu7du2PdunVPXI/l0KFDcHd3t3gt5uaQAfn0008hk8nMegLr9evXIyAgAKWlpYZ11dXVkEqlmDdvntnGMRf9WUa8vLyQkpJikW5y//59ZGRkICAgAFKpFJmZmS1ebqKsrAxvvPEGYmJiRL/4jqkcMiAvvvgiVqxYYdZtarVapKSk4Le//a3RCdDOnDkDDw8PbN261azjmYsluok+GP7+/pDJZK0Go6SkBNOnT4eLiwuGDBli+Hnu3LmiXXzHVA4XkCNHjsDFxcXoykjp6elYvXp1h7ddW1uL+Ph4TJo0yWj9tm3b4OHhgcLCwg6PYQnNu0l7Lwx69+5dLF26FH5+foiLi0N2dnaL12ApKytDamoqJBIJEhMT8R/9iQMBHDt2DLGxsZBKpfjpp5/a/ZisxeEC8s477yAlJcWwXF9fD39/f3zzzTdm2f6lS5fg6+uL9evXG61PTU1F9+7drXodQVOVlJRg0KBBCAoKMun/R1VVFZYuXQpfX1/07Nmz1WCUlpYagpGcnIyCgoIWt9fQ0GB0SlJTL0lnTQ4VEJVKBU9PT/zwww+GdVu3bkVwcLBJ1yl8mj179sDV1dXopMxqtRqJiYkYOnSoVS8nbSr9Zabb0k30wejcuTN+85vfIDs7u8V5XXFxMaZMmYJOnTohOTkZx48fb1MtBQUFiI2NRUREBA6dPNTux2RJDhWQDRs2QCqVGv0jJiYmYuHChWYfa+HChQgODjY6/f+NGzcQGhqKJUuWmH08c2tLN1m1ahX69u2L3NzcFi9FUVRUhClTpkAikWDMmDE4ceKEyXU0NDQgfWE6uud1R9q1NNRpzHsW+o5yqID06tULy5cvNywrFAo4OzvjypUrZh9Lo9Fg5MiRePnll40O8x4+fBiurq7497//bfYxzU3fTTw9PVvsJq1dAPX8+fNGwTh16lSHazn24Bhi5bGQFknx033bmZs4TEAKCgogkUiM3ribN28ehg4darExq6urIZPJMHv2bKP1q1evho+PDxQKhcXGNid9NwkODhYM9tmzZ5GSkoJOnTphzJgxZj8o0aBpQHplOiSFEqReTUWtRvy5icMEZPr06Rg/frxhuaGhAQEBARZ/o+zs2bPw9PTEli1bjNZPnToVPXr06PAVnaxFqJucOXPGEIyUlBSLB7/gQQF6yHtAViTDz/d/tuhYT+MQAVGpVPDy8sKBAwcM67Zt22b2yXlrcnJy4O7ujpMnTxrW1dfXo3fv3hg3bpxFLypqbgqFAv369UNISAhWrVqF4cOHQyKRYOrUqbh06ZLV6qjX1GPBrwvgUuiCow+OPv0OFuIQAfnss88QHh5udPRo4MCB+Oijj6xWw+zZsxEeHm70ylteXo4uXbrg73//u9XqMIempiZkZGRg3LhxmDZtmtUuxNOSc/XnoIUWaq0ac67NwayKWZhZMRPfKr+12LXRH+cQAenduzc+/vhjw/KFCxfg7OyMy5cvW60GtVqNgQMHYsiQIUZBzcvLg4uLC/Ly8qxWiyPaeGcjtt3dZlhu1DZaJSC2+82fNjp+/DgVFRXRtGnTDOuysrJo8ODB7f7CVHu4uLjQzp076eLFi7R48WLD+mHDhlFaWhqtX7/earU4ouL/FlOCV4Jh2dXJ1Srj2n1ANm3aRGPHjjVclKWxsZFycnJoxowZVq8lJCSE/vWvf9HBgwepsbHRsN7Ly4uqqqqsXo8jiXePp8L6QsOyGmqrjOsEAFYZyQJqa2vpueeeox07dtDIkSOJiOjLL7+k+fPnU2VlJbm5uYlSFwDDl600Gg3JZDJavHgxvfvuu6LU4wge4iHN/3U+gUBO5ETDOw+nem09+Un8aETnERYb166/UZiTk0N+fn40bNgww7qsrCyaPn26aOEgIqNvIn7//fd07949mjBhgmj1OAIXJxf6LPwzq49r17tYmzdvphkzZlCnTp2IiOjSpUt0+PBh+sMf/iByZY9kZWXR5MmTycfHR+xSWDvYbQc5efIknT9/nnJzcw3rsrKyKCkpiaKjo0Ws7JHKykrav38/nThxQuxSWDvZbQfJycmh5ORkeu655wzrfH19KS0tTcSqjG3evJl69+5Nffr0EbsU1k5220GioqIoNzfX6LyzS5YsEbeox2i1Wtq6dSv95S9/EbsU1gF2exSrsbGRBg0aRH5+fvT9998b5iG2Yu/evTRx4kS6fv06de7cWexyWDvZ7S6Wm5sbffPNN3T27FlatmyZ2OU8YdOmTTRp0iQOh52z2w6i9/PPP9OIESNo165dNHr0aLHLISKimzdvUnh4OB07doxeeuklscthHWC3HUTvtddeo08++YQmT55MJSUlYpdDRLruER8fz+FwAHbfQYh071y/9dZbdOHCBSooKCAvLy/RatFqtSSTyWjhwoU0c+ZM0epg5mH3HYRI9871li1bCIDoH+c4cOAAVVdX08SJE0Wtg5mHQwSEiMjb25t27dpFBw4coLVr14pWx6ZNm2jixIk8OXcQDrGL9bjvvvuO3nzzTcrLy6OkpCSrjn3r1i0KDw+nI0eOUEJCwtPvwGyew3QQvbFjx1J6ejpNmDCBKisrLTKGUqmkEydOUFlZmdH6zZs3U2xsLIfDgThcByHSTZTHjh1L1dXV9Msvv7Trk721tbV05coVo9vly5fpypUrVF1dTS4uLrRixQpasGCBYcyIiAj68MMPbfLCOqx9HDIgRLpX+YSEBEpOTqaNGze2+DdqtZoqKytbvNJUeXk5AaDQ0FDDVaYev8XHxxtd5uzAgQM0fvx4un79ut1dh4+1zmEDQkR0/vx5GjBgAK1bt87o6JZGo6HIyEiqqKggIqKwsDCKiooy3CIjIykmJoZkMhm5urbtq51vvPEGBQQE0ObNmy3yWJhILPqNdxuwfft2uLu7P3FazH379uHcuXOor69v97YfPnyIkpISfPXVV3BxccGxY8c6Wi6zMQ7dQfTmz59Pu3btosLCQgoMDDTpvlqtln799Ve6cuUKlZSUGM1FysvLSa1WU0BAAC1cuJA++OADCz0CJpZnIiBNTU2UnJxMzs7O9MMPP5BE8uSn/PVXvW0+H2ntqrfNb8wxPRMBISK6ffs29e3bl0aMGEEDBgwwdAP9ra6ujjw9PQ1zkMfnJNHR0RQcHCz2Q2AieGYCQkRUUFBAa9asIYVCYRQA/S0sLEzsEpmNeaYCwpipHO6ddMbMiQPCmAAOCGMCOCCMCeCAMCaAA8KYAA4IYwI4IIwJ4IAwJoADwpgADghjAjggjAnggDAmgAPCmAAOCGMCOCCMCeCAMCaAA8KYAA4IYwI4IIwJ4IAwJoADwpgADghjAjggjAnggDAmgAPCmAAOCGMCOCCMCeCAMCaAA8KYAA4IYwI4IIwJ4IAwJoADwpgADghjAjggjAnggDAmgAPCmAAOCGMCOCCMCeCAMCaAA8KYAA4IYwI4IIwJ4IAwJoADwpgADghjAjggjAnggDAmgAPCmAAOCGMC/h+kuhgnIa+8tgAAAABJRU5ErkJggg==" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Apoptosis Activator 2 is an indoledione caspase activator</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Apoptosis Activator 2 is a cell-permeable indoledione compound that activates caspases in a cytochrome c-dependent manner and induces apoptosis in tumor cells by promoting the oligomerization of Apaf-1 into the mature apoptosome. Its cytotoxicity is selective towards tumor cells (IC50 &lt; 10 μM for Jurkat, Molt-4, and CCRF-CEM). Apoptosis Activator 2 shows little or no effect on non-tumor cells or cells that are deficient in caspase-3 or Apaf-1. Apoptosis Activator 2 is an activator of caspase-3.\n</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.scbt.com/datasheet-202956-apoptosis-activator-2.html>http://www.scbt.com/datasheet-202956-apoptosis-activator-2.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">1901244</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/1901244>https://pubchem.ncbi.nlm.nih.gov/compound/1901244</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">5 (L1000FWD); 15 (TopoCMap)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K19687926</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Lapatinib</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C29H26ClFN4O4S</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Lapatinib is a 4-anilinoquinazoline kinase inhibitor of the intracellular tyrosine kinase domains \nof both epidermal growth factor receptor (HER1/EGFR/ERBB1) and \nhuman epidermal growth factor receptor type 2 (HER2/ERBB2)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">\nLapatinib is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug Capecitabine. Lapatinib is human epidermal growth factor receptor type 2 (HER2/ERBB2) and epidermal growth factor receptor (HER1/EGFR/ERBB1) tyrosine kinases inhibitor. It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding.\nMechanism of action\nLapatinib is a 4-anilinoquinazoline kinase inhibitor of the intracellular tyrosine kinase domains of both epidermal growth factor receptor (HER1/EGFR/ERBB1) and human epidermal growth factor receptor type 2 (HER2/ERBB2)with a dissociation half-life of ≥300 minutes. Lapatinib inhibits ERBB-driven tumor cell growth in vitro and in various animal models. An additive effect was demonstrated in an in vitro study when lapatinib and 5-florouracil (the active metabolite of capecitabine) were used in combination in the 4 tumor cell lines tested. The growth inhibitory effects of lapatinib were evaluated in trastuzumab-conditioned cell lines. Lapatinib retained significant activity against breast cancer cell lines selected for long-term growth in trastuzumab-containing medium in vitro. These in vitro findings suggest non-cross-resistance between these two agents.\nLapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">\nIndicated in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress the human epidermal receptor type 2 (HER2) protein and who have received prior therapy including an anthracycline, a taxane, and trastuzuma.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Lapatinib,http://www.selleckchem.com/products/lapatinib.html>http://en.wikipedia.org/wiki/Lapatinib,http://www.selleckchem.com/products/lapatinib.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">208908</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/208908>https://pubchem.ncbi.nlm.nih.gov/compound/208908</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB01259>https://go.drugbank.com/drugs/DB01259</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">26.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved; In top 10 iLINCS</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K20141153</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Atomoxetine</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C17H21NO</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">selective norepinephrine reuptake inhibitor (SNRI)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Atomoxetine is known to be a potent and selective inhibitor of the norepinephrine transporter (NET),2 which prevents cellular reuptake of norepinephrine throughout the brain, which is thought to improve the symptoms of ADHD. More recently, positron emission tomography (PET) imaging studies in rhesus monkeys have shown that atomoxetine also binds to the serotonin transporter (SERT),9 and blocks the N-methyl-d-aspartate (NMDA) receptor,10 indicating a role for the glutamatergic system in the pathophysiology of ADHD.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Atomoxetine,http://www.selleckchem.com/products/atomoxetine-hydrochloride.html>http://en.wikipedia.org/wiki/Atomoxetine,http://www.selleckchem.com/products/atomoxetine-hydrochloride.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">54840</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/54840>https://pubchem.ncbi.nlm.nih.gov/compound/54840</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00289>https://go.drugbank.com/drugs/DB00289</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">16.0</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved; In top 10 iLINCS</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K26756394</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">VE-821</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C18H16N4O3S</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">potent ATP-competitive inhibitor of the DNA damage response (DDR) kinase(ATM) and ATM- and Rad3-related (ATR)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">51000408</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/51000408>https://pubchem.ncbi.nlm.nih.gov/compound/51000408</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">2.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K28907958</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">CD-437</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C27H26O3</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">retinoid receptor agonist</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Antineoplastic Agent (substance that inhibit or prevent the proliferation of neoplasm)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">135411</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/135411>https://pubchem.ncbi.nlm.nih.gov/compound/135411</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">31</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 L1000FWD</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K31542390</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">mycophenolic-acid</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C17H20O6</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Mycophenolic acid is an immunosuppressant used to prevent organ transplant rejections.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Mycophenolic acid is a potent, selective, uncompetitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Because T- and B-lymphocytes are critically dependent for their proliferation on de novo synthesis of purines, whereas other cell types can utilize salvage pathways, mycophenolic acid has potent cytostatic effects on lymphocytes. Mycophenolic acid inhibits proliferative responses of T- and B-lymphocytes to both mitogenic and allospecific stimulation. Addition of guanosine or deoxyguanosine reverses the cytostatic effects of mycophenolic acid on lymphocytes. Mycophenolic acid also suppresses antibody formation by B-lymphocytes. Mycophenolic acid prevents the glycosylation of lymphocyte and monocyte glycoproteins that are involved in intercellular adhesion to endothelial cells and may inhibit recruitment of leukocytes into sites of inflammation and graft rejection.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used to prevent organ transplant rejections.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Mycophenolic_acid>http://en.wikipedia.org/wiki/Mycophenolic_acid</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">671222</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/671222>https://pubchem.ncbi.nlm.nih.gov/compound/671222</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB01024>https://go.drugbank.com/drugs/DB01024</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">37 (L1000FWD); 42 (TopoCMap)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K33106058</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Cytarabine</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C9H13N3O5</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Cytarabine (Cytosine arabinoside, AraC) is an antimetabolic agent and DNA synthesis inhibitor with IC50 of 16 nM in wild-type CCRF-CEM cells.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Cytarabine acts through direct DNA damage and incorporation into DNA. Cytarabine is cytotoxic to a wide variety of proliferating mammalian cells in culture. It exhibits cell phase specificity, primarily killing cells undergoing DNA synthesis (S-phase) and under certain conditions blocking the progression of cells from the G1 phase to the S-phase. Although the mechanism of action is not completely understood, it appears that cytarabine acts through the inhibition of DNA polymerase. A limited, but significant, incorporation of cytarabine into both DNA and RNA has also been reported.\n</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.\n\nCytarabine is indicated in combination with daunorubicin for the treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Cytarabine,http://www.selleckchem.com/products/Cytarabine(Cytosar-U).html>http://en.wikipedia.org/wiki/Cytarabine,http://www.selleckchem.com/products/Cytarabine(Cytosar-U).html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">6253</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/6253>https://pubchem.ncbi.nlm.nih.gov/compound/6253</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00987>https://go.drugbank.com/drugs/DB00987</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">9.0</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved; In top 10 iLINCS</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K34098590</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Ticrynafen</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C13H8Cl2O4S</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">sodium/potassium/chloride transporter inhibitor, cytochrome P450 inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Tienilic acid, or ticrynafen, is a diuretic drug with uric acid-lowering action which was marketed for the treatment of hypertension. It was withdrawn in 1982 after case reports in the United States suggested a link between ticrynafen and hepatitis. (Manier et al., 1982)\nsodium/potassium/chloride transporter inhibitor, cytochrome P450 inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">\nFor the treatment of hypertension.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Tienilic_acid>http://en.wikipedia.org/wiki/Tienilic_acid</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">38409</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/38409>https://pubchem.ncbi.nlm.nih.gov/compound/38409</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB04831>https://go.drugbank.com/drugs/DB04831</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">43.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K47943470</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">tyrphostin-51</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C13H8N4O3</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">GPR35 agonist</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Tyrphostin-51 was found to cause internalization of GPR35, phosphorylation of extracellular signal-regulated kinase (ERK) and translocation of b -arrestin via GPR35. Furthermore, the tyrphostin-51 DMR can be blocked by a known GPR35 antagonist. However, for certain ligands, the dose response can be biphasic, leading to dual efficacy.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5328807>https://pubchem.ncbi.nlm.nih.gov/compound/5328807</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">5328807</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5328807>https://pubchem.ncbi.nlm.nih.gov/compound/5328807</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">CLUE</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">39</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster 1 and UMAP cluster 1; In top 10 CLUE</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K50841342</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">PAC-1</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C23H28N4O2</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">caspase activator</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">PAC-1 has been used in trials studying the treatment of Lymphoma, Melanoma, Solid Tumors, Breast Cancer, and Thoracic Cancers, among others.\nPAC-1 is a potent procaspase-3 activator with EC50 of 0.22 μM.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used in trials studying the treatment of Lymphoma, Melanoma, Solid Tumors, Breast Cancer, and Thoracic Cancers, among others.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.selleckchem.com/products/pac-1.html>http://www.selleckchem.com/products/pac-1.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">5344054</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5344054>https://pubchem.ncbi.nlm.nih.gov/compound/5344054</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB13048>https://go.drugbank.com/drugs/DB13048</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">30</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 L1000FWD</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K51418664</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BIM0133</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C15H18N4O5</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">DNA alkylating agent, DNA synthesis inhibitor</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Mitomycin is one of the older chemotherapy drugs, which has been around and in use for decades. It is an antibiotic which has been shown to have antitumor activity. Mitomycin selectively inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree of mitomycin-induced cross-linking. At high concentrations of the drug, cellular RNA and protein synthesis are also suppressed. Mitomycin has been shown in vitro to inhibit B cell, T cell, and macrophage proliferation and impair antigen presentation, as well as the secretion of interferon gamma, TNFa, and IL-2.\n\nMitomycin is activated in vivo to a bifunctional and trifunctional alkylating agent. Binding to DNA leads to cross-linking and inhibition of DNA synthesis and function. Mitomycin is cell cycle phase-nonspecific.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">For treatment of malignant neoplasm of lip, oral cavity, pharynx, digestive organs, peritoneum, female breast, and urinary bladder. Also used as an adjunct to ab externo glaucoma surgery. Mitomycin is also indicated as a pyelocalyceal solution for the treatment of adults with low-grade upper tract urothelial cancer (LG-UTUC)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.scbt.com/datasheet-3514-mitomycin-c.html,http://www.selleckchem.com/datasheet/Mitomycin-C-DataSheet.html>http://www.scbt.com/datasheet-3514-mitomycin-c.html,http://www.selleckchem.com/datasheet/Mitomycin-C-DataSheet.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">15560563</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/15560563>https://pubchem.ncbi.nlm.nih.gov/compound/15560563</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00305>https://go.drugbank.com/drugs/DB00305</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">49.0</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K54006094</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">formoterol</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C19H24N2O4</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">An inhaled long-acting beta2-adrenergic receptor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Formoterol is a relatively selective long-acting agonist of beta2-adrenergic receptors,10,16 although it does carry some degree of activity at beta1 and beta3 receptors.9 Beta2 receptors are found predominantly in bronchial smooth muscle (with a relatively minor amount found in cardiac tissue) whereas beta1 receptors are the predominant adrenergic receptors found in the heart - for this reason, selectivity for beta2 receptors is desirable in the treatment of pulmonary diseases such as COPD and asthma.10 Formoterol has demonstrated an approximately 200-fold greater activity at beta2 receptors over beta1 receptors.10\n\nOn a molecular level, activation of beta receptors by agonists like formoterol stimulates intracellular adenylyl cyclase, an enzyme responsible for the conversion of ATP to cyclic AMP (cAMP). The increased levels of cAMP in bronchial smooth muscle tissue result in relaxation of these muscles and subsequent dilation of the airways, as well as inhibition of the release of hypersensitivity mediators (e.g. histamine, leukotrienes) from culprit cells, especially mast cells.10</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used as a bronchodilator in the management of asthma and COPD.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Formoterol>http://en.wikipedia.org/wiki/Formoterol</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">23581795</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/23581795>https://pubchem.ncbi.nlm.nih.gov/compound/23581795</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00983>https://go.drugbank.com/drugs/DB00983</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">8 (L1000FWD); 32 (TopoCMap)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K54233340</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">dorsomorphin</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C24H25N5O</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMgAAADICAYAAACtWK6eAAAS+ElEQVR4nO3de1BU993H8Q8iKMrNQFJFG3RyAXRiRFQE0eGyC5aoVCMk1dAH7BMyanRMJGjHzNip7QPGJI19mnZgxraxNMmMSUwhQeCs4KXIZIQYqEGkBVFRrHJREUUu+33+2AdEJb+w7AW0n9c/Xpbz47eyb85yzu8cHUREQEQDGjXcEyAayRgIkQIDIVJgIEQKDIRIgYEQKTAQIgUGQqTAQIgUGAiRAgMhUmAgRAoMhEiBgRApMBAiBQZCpMBAiBQYCJECAyFSYCBECgyESIGBECkwECIFBkKkwECIFBgIkQIDIVJgIEQKDIRIgYEQKTAQIgUGQqTAQIgUGAiRAgMhUmAgRAoMhEiBgRApMBAiBQZCpMBAiBQYCJECAyFSYCBECgyESIGBECkwECIFBkKkwECIFBgIkQIDIVJgIEQKDIRIgYEQKTAQIgUGQqTAQIgUGAiRAgMhUmAgRAoMhEiBgRApMBAiBQZCpMBAiBQYCJECAyFSYCBECgyESIGBECkwECIFBkKkwECIFBgIkQIDIVJgIEQKDIT6fP454OcHdHUB9fVAaupwz2j4MRC6y/z5QFbWcM9i5GAgdBe9HigtBW7cMP35+HFg717Tr21twzu34TB6uCdAI8/rrwPvvgs88ghw8iSQkQHU1QHd3UBc3Be4det/ERAQgICAACxduhQ+Pj7DPWWbYSB0n9mzTT+HAEByMhATA3h7AzU1QG2tNyorw1BVVYWCggJ88skn0DRteCdsQw4iIsM9iV4NDQ04ePAgxo4dC71ej0ceeWS4p/Qfo6UF8PQERt3zpru52RSHhwfg7w/Mnr0VU6c+gunTp2PKlCkIDAxEU1MTvLy8hmXetjasgVy7dg3FxcUwGAw4ePAgqqur8cQTT8DLywvd3d3QNI2R2MmyZaYjWLt23f/YuXNAdTVQXS2oqlqHU6eqUFVVhWPHjuGZZ55BUVERQkND7T9pO7BrIN3d3aioqIDBYIDBYMDhw4fh4eGBiIgI6HQ66PV6TJs2De3t7Xjuuedw7do1GAyGh/a700hRVgaEhAD/+IdpL2GOGTNmYPPmzVizZo1tJjfM7BJIR0cH0tPT8fbbbwMAFi1ahKioKOh0Ojz77LNwcHC4b5v29nbExsaira0NBoOBexIbeu454NFHgT//2fxtn3/+eTz55JPYuXOn1ec1EtglkNzcXCQmJuKzzz7DggULMGbMmEFtx0jso64OcHYGpkwxf9tt27bh5MmT+Nvf/mb9iY0AdjkPomkaoqOjERkZOeg4AGD8+PHIzc3FmDFjoNPp0NLSYsNZ/ue494z5738/tDgAwM/PD6dPn7bm9EYUuwRSWFgIvV4/pG3d3d1RUFCAMWPGQK/XMxIrsdYZc39/f9TW1qKzs9PywUYgmwfS0NCA06dPQ6fTDXkMd3d35Ofnw8nJCXq9Hq2trVac4X+me8+YD5W/vz96enpQW1trnYmNMDYPpKCgAE899RSmTZtm0TgeHh7Iz8+Ho6MjVq9ebaXZPfxu3QIMBmDrVmDOHKCw8M5jvWfMh+r48eNwd3fHpEmTUF1dbflkRyCbB6Jp2pDfXt3L09MT7777LkpLS3Hr1i2rjPmwMRqNKC8vx86dO6HX67Fs2Q6sWAF8+y2QmAjMmHHnY/ufMTdHYWEhQkJCEB4ejsbGRvj7+1stkMLCQrz44otYvnw5KisrrTKmRcSGenp65NFHH5X9+/dbbcxdu3ZJcHCw1cZ72Lzxxhvi5OQkYWFh8otf/EJKSk5IV9fgtm1tVT9+9OhRiYiIEGdnZ0lJSZELFy5IXl6eBAQEyMyZM+XTTz8Vo9E4pHk3NzdLUlKSODs7y6uvvirx8fHi6OgoCQkJUlVVNaQxrcGmgZSXl8vo0aPl6tWrVhszOjpa3nzzTauN9zC5cuWKjBo1SsrKyszetqtL5OmnRdLT73/s73//u0RFRfWF0dDQIAUFBTJ//nwZN26cbNy4UTZv3ixubm4ye/Zsyc3NNetz5+TkyOTJk2XWrFlSXl4uHR0dUlFRISdPnuwLJT4+Xk6fPm3287KUTQNJT0+X0NBQq41365ZRnn02VA4fPmK1MR8mH374oUyePFmuX78uERERcunSJbO2P3xYZPx4kV/9yvTn2tpaiYyMFGdnZ1m7dq2cP39+wL1Ir6amJtm+fbu4ublJcHCw5OTkKD9fY2OjrFy5UlxcXCQjI0O6u7tFRCQvL++uvUdlZeVdofzrX/8y7x/GAjYNJDIyUrZv32618TTN9AXs6LDakA+V5ORkSU5OlpycHJkwYULfC84cmiai070jO3fulNbWVnn11Velvr5+wL3Id7l8+bJs2bJFXFxcJDQ0VAwGw12PG41G+eCDD8TLy0sWLlw44J5hoL1HaWmpLFmyRJycnCQlJUXOnz9v9vMzl80C6e7ulkmTJn3vdxFzpKWJLFliteEeOj/84Q/lww8/lA0bNkh8fPyQxyksLBQXFxf59a9/LSUlJX0vysTERKmrqxv0OOfPn5eNGzfK2LFjZcGCBXLo0CGpra0VnU4nHh4ekpmZ+b0/swy09yguLpawsDBxc3OT6urqIT/PwbDpHmTVqlUSEBBg9q7+uwQGiuzebZWhht2tW7esOl5VVZU4ODhIY2Oj+Pv7S1ZWlkXjFRYWiqenZ99367Nnzw55rDNnzsiaNWtk9OjR4uXlJStWrJCLFy+aNUZJSUnfHmzt2rVy8+ZNWbZsmWzatGnI8xoMmwbS0dEhsbGx4ufnZ/Y/yL2MRpFNm0Rqaqw0OTu7ceOGaJomW7ZskaCgIHnmmWckJSVFenp6rDL+7t27ZdasWXL+/HkBYNZ3+oF0dXWJh4eHZGdnW2V+IiJvvfWW+Pn5SVdXl3z77bfSNdjDa/0cOnRI1q1bJyIia9eulZ/97GdWm99AbBqIiMjNmzdFp9OJv7+/xZE8SLq6uqSsrEwyMjJEp9OJs7OzeHt7S3x8vGRmZsoXX3whkyZNkuTkZKtEsmTJEklLS5M9e/bIk08+afF4JSUl4uzsLDdu3LB4rF6ffvqp+Pr6yuXLlwWAnDt3zqLx0tLSJCEhwUqzG5jNTxS6uLggJycHkydPRmRkJC5dumTW9g/SrWgaGhrwzjvvIDY2Fp6enli0aBGKiooQHR2N0tJSnDt3DmvXrsXZs2cRFBSE4uJi5Ofn4+WXX4bRaBzy5+3u7saRI0eg1+utdmK2sLAQYWFhGD9+vMVj9XJzc0NbWxvc3NwAAG0W3gXisceegqvrE9aY2neyy2LF3kh8fHwQERFhdiQPwq1oenp6kJycjOzsbAQGBiI3NxdNTU1IT08HAPz85z+Ht7c3li5dihMnTqC1tRV+fn4oLi7GgQMHLIrk2LFj6OzsRGhoKIqKiqwSyNmzz+LHP15n8Tj99QYyduxYODk5WRzI6NH/jZqa/7HS7AZmt9v+jBs3Drm5ufDx8VHuSYxG4OuvTWuEenpMf2ethXW2dPz4cRw5cgRHjx7FnDlz8Ic//AGPP/44goODsX//fgQHByMvLw8tLS3Iy8tDQEAAANNy8aKiIuTl5Q05Ek3TsHDhQtTU1KClpQUREREWPZe2NuCvf12O0NDnLRrnXm5ubujq6sLt27fh6upqcSCurrZ/Tdj1ria9kSxZsgQxMTE4ePAgvL29UVdXB4PBgBMnXsAnn3jg6lVg7lxg1ao72/a/Fc1IpGkaQkJC4OrqijNnzmDixInYs2cPwsPD4e7urtzW398fxcXFiIiIQEpKCrKysjDq3rsn3KO+vr7v0uUTJ05g5syZmDVrFmpqauDp6WnRcykqAtzdgcBAi4a5j6urKwDgxo0bcHNzww0LX91ubra/V5fdb/vTG0lsbCx0Oh3a2tpQV1eHgIAA/OQnodizxwPh4aYvUH9DXVhnL5qmISYmBgDw+uuvm719/0heeeUVZGZm3hVJc3MzioqKcPDgQRgMBtTW1sLf3x9RUVFISUnBjh07sHXrVmRkZFjhuQA63f13OLFU/589rLEH8fU1vf22KZseAlBoa2uT/fv3ywcffHDXcoXBaGkRSUkRuXbNRpMz0/Xr18XJyUm++uori8eqqqqSiRMnSlJSkhQUFEhaWpoEBQXJqFGjZOLEifLSSy/Jn/70p/vOIpeVlcmECRNk8+bNVpiDSGWlxcPcp7OzUwBIZWWlBAcHy/vvv2/9T2JlwxaIJVpbRebOFQkJMT+Sy5cvS1VVlXRYcb2KJUs7+us9L1BRUSHTpk0TFxcX0el0kpGRIWVlZd971rk3ktTUVLM/9/79psWKnZ0iZ86IWKGzAY0ZM0ZKSkr6ntdQ2Wu+D+S9eT09gYIC4PZtYP36euWuur29Hfn5+UhNTUVgYCB+8IMf4IUXXsDSpUutdk2JpmmIioqCo6OjReNkZWVBr9fjscceQ319Pb755htomoYtW7YgKChowLu/9BcUFIQvv/wSWVlZeOONNwb8GKMRKC8Hdu4EYmOBjo47j9njaGHvkSxvb290d3dbNJY95vtABgIAEyYAmmZETc1L+NGPftQXSU9Pz10XDHl5eWHlypWoqKjAiy++iOPHj0PTNFy8eBFxcXFWicSa5x5mzpyJgoIC+Pr64umnnzZ7jJCQEOTn5yMrKwtpaWkAgM7OTmRmZiI+Ph4+PlOg1wtyckwHQm7fvrOtPY4Wurq6or6+Hh999BG2bds26O0MhrvnCtjp6KZtdkz209zcLIGBgTJ79myJi4sTDw8PcXZ2lvDwcNmxY4eUlpYO+NansbFRXomMlJsvvCBiwbqohoYGqy7tOHDggKxevVpSUlIsGq+kpETc3NwkLS1NjEajLFy4UDZu3Cg5OTly7VqHVFeLvP++yPLlIl98YXrL8pe/iJSXiyQn2+4ty+9+9ztxdnaWdevWKVcE97pyRWT1ahFnZ5Hi4jt/b6/5PvCBiJiuQ3jvvfckNTVVDhw4IO3t7YPb8NIlkenTRaKjhxyJtZd2tLW1yaRJk2Tfvn1WGbM3ksbGRsnOzpakpCSJi/tSHBxEZs4Uee010w/kvS84EZGXXrLdC07EdAFW/2tKvmsJ0kcffSQ63bsyf77IyZOm61Xmzzd92ew134ciEItcuCDi5yfyxz8OafMVK1b0rS5NTU0d8tWT27dvl8jISPnmm2/E0dFRmpubhzTOvY4ePSpTp04VBwcHefzxx2XNmjWyb59BrLTA2iKapsm8efP6rkrsv+o7ISFBXF1d5b333pOmph5JSjLtRd58077XAzEQERFzXtQXLsjH2dny05/+VHx8fGTKlCkSExMjV65ckTlz5khISIhcG8Lx59DQUElPT5ddu3bJvHnzzN5e5fbt21IzgpdBa5omQUFB4urqKlu2bJGWlhb57LPP5MyZM7Jv3z4JCFgkUVGdUlFh/7kxkP46O0XWrxfZuFEkMfHOm95Tp0Q2bDC9HQPkvxYvlpdfflk+/vhj+frrr2Xq1KmycuVKaWpqknnz5pkdSe95lLKyMomOjpZt27bZ5vmNYEajUfbt2yczZsyQCRMmyNatWyUuLk7GjRsnb7/9tsWH0IeKgfSXmSmyd6/p993dIlFRpt9/9ZVIQoLp8QGuh66vr5epU6dKfHy8XLlyRebOnWtWJJ9//rl4eXlJe3u7jBs3Tg4dOmStZ/TA6enpkezsbImKipLly5fb9frzgTCQ/jZsMO0teq1aZTptPwgDRRIaGirXr1//3m1/85vfSGJiomiaJuPHj7fqSUyyzAN7HsQmpk83nUUDTGfU/v1v0wmXQfD19YWmaTh27BjWr1+PvLw8dHZ2YvHixd+75mjTpk3Yu3cvNE1DeHi4WTf4JtsaUf8F27Dr6gI2bQIcHYGrV4GkJCAy0qwh/vnPfyIiIgILFizAb3/7WyxevBhTpkxBbm7ugB/fu5LZYDDg1KlT+OUvf4nly5db/FTIOhiIDfRGEhYWht27d+PixYsI/P+14/2XqRcVFaGlpQVz5syBTqdDdHQ0Fi1aNMyzp/4YiI30RhIcHIyEhIS+/4ux/zJ1nU6H8PBwi6/fINthIDZ0+vRpvPbaaygrK0N4eDh0Oh1iYmLg6+s73FOjQWIgNiYi37sKl0YuHsWyMcbxYGMgRAoMhEiBgRApMBAiBQZCpMBAiBQYCJECAyFSYCBECgyESIGBECkwECIFBkKkwECIFBgIkQIDIVJgIEQKDIRIgYEQKTAQIgUGQqTAQIgUGAiRAgMhUmAgRAoMhEiBgRApMBAiBQZCpMBAiBQYCJECAyFSYCBECgyESIGBECkwECIFBkKkwECIFBgIkQIDIVJgIEQKDIRIgYEQKTAQIgUGQqTAQIgUGAiRAgMhUmAgRAoMhEiBgRApMBAiBQZCpMBAiBQYCJECAyFSYCBECgyESIGBECkwECIFBkKkwECIFBgIkQIDIVJgIEQKDIRIgYEQKTAQIgUGQqTAQIgUGAiRAgMhUmAgRAoMhEiBgRApMBAiBQZCpPB/Pc1Zy9FIoBYAAAAASUVORK5CYII=" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Activin receptor type-1; Peptidyl-prolyl cis-trans isomerase FKBP1A</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">experimental</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.biovision.com/dorsomorphin-3028.html>http://www.biovision.com/dorsomorphin-3028.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">11524144</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/11524144>https://pubchem.ncbi.nlm.nih.gov/compound/11524144</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB08597>https://go.drugbank.com/drugs/DB08597</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">17</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 TopoCMap</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K57033106</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Tripelennamine</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C16H21N3</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Histamine receptor antagonist.Tripelennamine is a widely used H1 antagonist, inhibiting PhIP glucuronidation</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Tripelennamine Hydrochloride is the hydrochloride salt form of tripelennamine, an ethylenediamine derivative with an antihistaminergic property. Tripelennamine hydrochloride competitively blocks central and peripheral histamine H1 receptors, thereby limiting histamine's effects, including bronchoconstriction, vasodilation, increased capillary permeability, and spasmodic contractions of gastrointestinal smooth muscle. In addition, this agent binds to muscarinic receptors, resulting in anticholinergic activity.\nhistamine receptor antagonist.Tripelennamine is a widely used H1 antagonist, inhibiting PhIP glucuronidation with IC50 of 30 μM.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">\nUsed for the symptomatic relief of hypersensitivity reactions, coughs, and the common cold</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Tripelennamine,http://www.selleckchem.com/products/tripelennamine-hydrochloride.html>http://en.wikipedia.org/wiki/Tripelennamine,http://www.selleckchem.com/products/tripelennamine-hydrochloride.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">9066</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/9066>https://pubchem.ncbi.nlm.nih.gov/compound/9066</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00792>https://go.drugbank.com/drugs/DB00792</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">30.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K57954781</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K57954781</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C10H13N5O3</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Cordycepin has been used in trials studying the treatment of Leukemia.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Cordycepin has displayed cytotoxicity against some leukemic cell lines in vitro, and at least one clinical trial of cordycepin as a leukemia treatment is in progress.[5]\n\nCordycepin has been found to produce rapid, robust imipramine-like antidepressant effects in animal models of depression, and these effects, similarly to those of imipramine, are dependent on enhancement of AMPA receptor signaling.[6]\n</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used in trials studying the treatment of Leukemia.\n</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">23581797</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/23581797>https://pubchem.ncbi.nlm.nih.gov/compound/23581797</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB12156>https://go.drugbank.com/drugs/DB12156</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">48 (L1000FWD); 16 (TopoCMap)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K58550667</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">FK-866</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C24H29N3O2</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Target: Nicotinamide phosphoribosyltransferase</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Daporinad has been used in trials studying the treatment of Melanoma, Cutaneous T-cell Lymphoma, and B-cell Chronic Lymphocytic Leukemia.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used in trials studying the treatment of Melanoma, Cutaneous T-cell Lymphoma, and B-cell Chronic Lymphocytic Leukemia.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">6914657</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/6914657>https://pubchem.ncbi.nlm.nih.gov/compound/6914657</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB12731>https://go.drugbank.com/drugs/DB12731</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">10 (L1000FWD); 7 (TopoCMap)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K59574735</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">ubenimex</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C16H24N2O4</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">A competitive protease inhibitor; an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">It is being studied for use in the treatment of acute myelocytic leukemia.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Ubenimex>http://en.wikipedia.org/wiki/Ubenimex</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">72172</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/72172>https://pubchem.ncbi.nlm.nih.gov/compound/72172</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB03424>https://go.drugbank.com/drugs/DB03424</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">3</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 TopoCMap</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K60866521</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Idelalisib</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C22H18FN7O</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">inhibits P110δ, the delta isoform of PI-3K</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Idelalisib specifically inhibits P110δ, the delta isoform of the enzyme phosphatidylinositol-4,5-bisphosphate 3-kinase, also known as PI-3K. The PI-3Ks are a family of enzymes involved in cellular functions such as cell growth, proliferation, differentiation, motility, survival and intracellular trafficking, which in turn are involved in cancer. In contrast to the other class IA PI3Ks p110α and p110β, p110δ is principally expressed in leukocytes (white blood cells) and is important for the function of T cells, B cell, mast cells and neutrophils. By inhibiting this enzyme, idelalisib induces apoptosis of malignant cells and inhibits several cell signaling pathways, including B-cell receptor (BCR) signaling and C-X-C chemokine receptors type 5 and type 4 signalling, which are involved in trafficking and homing of B-cells to the lymph nodes and bone marrow. Treatment of lymphoma cells with idelalisib has been shown to result in inhibition of chemotaxis and adhesion, and reduced cell viability.\nCAL-101 is a selective PI3K class I inhibitor of p110&amp;#948; with IC50 of 2.5 nM. - See more at: http://www.selleckchem.com/products/CAL-101.html#sthash.ERygdn1C.dpuf</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">\nIdelalisib is indicated in the treatment of chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL). For the treatment of relapsed CLL, it is currently indicated as a second-line agent in combination with rituximab in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities, while in the treatment of FL and SLL it is intended to be used in patients who have received at least two prior systemic therapies.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.selleckchem.com/products/CAL-101.html>http://www.selleckchem.com/products/CAL-101.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">11625818</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/11625818>https://pubchem.ncbi.nlm.nih.gov/compound/11625818</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB09054>https://go.drugbank.com/drugs/DB09054</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">28.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved; In top 10 iLINCS</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K68191783</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">SCHEMBL15556278</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C23H18F3N5O3</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Binds Human EphA3 kinase domain</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">24880028</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/24880028>https://pubchem.ncbi.nlm.nih.gov/compound/24880028</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">12.0</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; In top 10 iLINCS</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K70401845</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Erlotinib</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C22H23N3O4</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase\n(It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR))</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Erlotinib is indicated for:\n\nThe treatment of metastatic non-small cell lung cancer (NSCLC) with tumors showing epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations.\n\nIn combination with first-line treatment for patients diagnosed with locally advanced, unresectable or metastatic pancreatic cancer.\n\nThe safety and efficacy of erlotinib have not been established for patients with NSCLC whose tumors show other EGFR mutations. Additionally it is not recommended for use in combination with platinum-based chemotherapy.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Erlotinib,http://www.selleckchem.com/products/desmethyl-erlotinib-cp-473420.html>http://en.wikipedia.org/wiki/Erlotinib,http://www.selleckchem.com/products/desmethyl-erlotinib-cp-473420.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">176871</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/176871>https://pubchem.ncbi.nlm.nih.gov/compound/176871</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00530>https://go.drugbank.com/drugs/DB00530</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">22.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; In top 10 iLINCS</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K71879491</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">tretinoin</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C20H28O2</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Tretinoin binds to alpha, beta, and gamma retinoic acid receptors (RARs)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Tretinoin binds to alpha, beta, and gamma retinoic acid receptors (RARs). RAR-alpha and RAR-beta have been associated with the development of acute promyelocytic leukemia and squamous cell cancers, respectively. RAR-gamma is associated with retinoid effects on mucocutaneous tissues and bone. Although the exact mechanism of action of tretinoin is unknown, current evidence suggests that the effectiveness of tretinoin in acne is due primarily to its ability to modify abnormal follicular keratinization. Comedones form in follicles with an excess of keratinized epithelial cells. Tretinoin promotes detachment of cornified cells and the enhanced shedding of corneocytes from the follicle. By increasing the mitotic activity of follicular epithelia, tretinoin also increases the turnover rate of thin, loosely-adherent corneocytes. Through these actions, the comedo contents are extruded and the formation of the microcomedo, the precursor lesion of acne vulgaris, is reduced. Tretinoin is not a cytolytic agent but instead induces cytodifferentiation and decreased proliferation of APL cells in culture and in vivo. When Tretinoin is given systemically to APL patients, tretinoin treatment produces an initial maturation of the primitive promyelocytes derived from the leukemic clone, followed by a repopulation of the bone marrow and peripheral blood by normal, polyclonal hematopoietic cells in patients achieving complete remission (CR). The exact mechanism of action of tretinoin in APL is unknown.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/444795>https://pubchem.ncbi.nlm.nih.gov/compound/444795</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">444795</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/444795>https://pubchem.ncbi.nlm.nih.gov/compound/444795</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00755>https://go.drugbank.com/drugs/DB00755</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">CLUE</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">36</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster 1 and UMAP cluster 1; FDA approved; In top 10 CLUE</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K73789395</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">ZM-336372</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C23H23N3O3</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">was screened as the first compound-suppressing BRAF, as well as CRAF, and the feedback loop for RAF</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">The first-generation RAF inhibitors When RAF was first introduced as a target for cancer treatment, before the discovery of BRAFm, the first-generation inhibitors of RAF were small-molecule ATP-competitive inhibitors, which were explored to target CRAF in cancer. 39 ZM336372 was screened as the first compound-suppressing BRAF, as well as CRAF, in vitro, and the feedback loop for RAF appeared to suppress its own activation. 39 Sorafenib (Nexavar®, BAY43-9006) is the only first-generation RAF inhibitor that has gained approval from the US FDA; however, sorafenib exhibits weak antitumor activity in cells with BRAF-V600E and its clinical efficacy in the abovementioned cancers with WT BRAF might be attributed to its multikinase profile. No PFS benefit was detected from the addition of sorafenib to first-line mFOLFOX6 for mCRC in the RESPECT trial.40 Additionally, the combination of sorafenib and irinotecan41 or cetuximab42 had been evaluated in a trial for KRAS-mutated CRC; however, low or no objective responses were observed. Other first-generation RAF inhibitors, such as SB-590885,43 GDC-0879,44 GW5074,45 and L779450,46 were not applied in clinical practice (Figure 4).</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5730>https://pubchem.ncbi.nlm.nih.gov/compound/5730</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">5730</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5730>https://pubchem.ncbi.nlm.nih.gov/compound/5730</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">CLUE</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">45</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster 1 and UMAP cluster 1; In top 10 CLUE</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K74765201</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">tomelukast</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C16H22N4O3</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMgAAADICAYAAACtWK6eAAAQDElEQVR4nO3dfUxUV/4G8C8CA0iRF19KUVoVWWBbtVVbcV3bKmJqGRO7UWssuJi6auq7axY1a4hr/2CrMWDdGlezFjVNauLaQvuzClt8Z33Xol2qKOLgu4gKCDLOPL8/rrxZPA4zc2EGns8/zMC995ybOc+cc2fuOXgAgBBRszq1dQWIXBkDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkQIDQqTAgBApMCBECgwIkYLLBaSoqEiqq6vbuhpEIuKCAXn99dfl6NGjbV0NIhFxwYBYLBbx9PRs62oQiYgLBsRqtUqnTi5XLeqgXK4lsgchV+JyAWEPQq7EpVoiAAHAgJDLcKmWaLVaRUQ4xCKX4VIBsVgsIiLsQchluFRLZA9CrsalAsIehFyNS7XEuh6EASFX4VItkUMscjUuFRAOscjVeLV1BUREzGazfPHFF/Ltt9+KCHsQch1t/ladnZ0tMTExsmrVKhk3bpz069dPcnJydC3z7NmzsmvXLrl165au5VA7gLZy/Dg+fO89+Pv7Y8WKFaiqqgIALFmyBP7+/oiLi8O5c+ecWuTNmzcxa9YseHl54c0330RQUBDS09NhNpudWg61H60fkNJS4I9/BLy8cGrpUly9ehUAcPnyZUyePBleXl7YsmULkpKS4O3tjXnz5uHevXsOFVlbW4v09HQEBgZiyJAh2L9/P6xWK7Zv347w8HBERUXhhx9+cMLJUXvTegGpqgLS0oCAACA2Fjh8GABQWVmJ1NRU+Pn5IS4uDqdPn67fZd++fRgwYAC6du2K9PR0WCyWFheblZWFiIgI9OzZExs2bIDFYoHVakVFRUWT8n18fGA0GlFcXOyU06X2ofUCsns30K8fsGOH9vzxY2DjRhS99x6io6Px3XffNbubxWJBZmYmunXrhsGDB+Pwk2A9z/Hjx/H222/D398fKSkp9YE4dOgQhg4dimnTpjXZ/vz58xg7diw6d+6M1NRUVFdX23+u5BQ7dwK/+Q1QWwsUFwN//nPr16F1h1i1tdrP3Fxg4ECga1dY16616RqgrKwM8+bNg5eXF5KSknDjxo1mtystLcWMGTPqt7t27RoAwGQyISkpCZ6ensr9s7Ky0KdPH0RERGD79u12nSY5x86dwNSpwLp17S0gtbXA7NnAvHlAUhKQl6f93mIB/vAHwGAAFi4E7t5t8aFPnjyJ4cOHIygoCGlpaXj06BEAoKqqCmlpaQgICMDIkSNx8uRJAA1DKF9fX8TFxeHMmTPPLePhw4dIS0vDCy+8oMuHBdS8R4+AY8eAo0e15zt3Alu3Ah99BBQUtKeAbNgAbNmiPX78GIiLa/jbpk3A+fMOHd5qteLLL79EaGgo+vfvj+XLlyMsLAyRkZH45ptvADQMzUJDQxEVFWVXb1DX69R9WHD//n2H6t0RPWuYZDYDp04BGzcCs2YBQ4Zo75uentrzun23bgVOnACmTWtPAZk7F/jf/xqeT5liV2/xPPfv38f06dMRGRmJNWvW1Pcmubm5GDhwIEJCQpr0Mvbas2cP+vXrh/nz5zuh1h1Lc8Okhw+Bzp2BTp2AmBhtkJGRARw8qH2W03jfrVu1x4mJ7Skg69cD27Zpjy2Wpj2Ikx06dAgGgwEAUF1djYSEBBgMBixevBjl5eVOK+err75C3759nXa8juJZw6T//hd48KBlx2qLDxj1+Sb9449FDh8WmTdPJDlZZNkyXYoRaTqH3dfXV0aMGCE///yzrFq1SoKCghw6dl5enkRERNQ/5y0w9lu0SGTNmobnQ4eKBATYvv+ZMyJRUSJFRc6vm4o+92J5e4v84x+6HPppT6+CkpKS4rRj19TUSEVFhYhwMQlHDRokYjbbt++NGyIDB4qMGSPyl7+I/Pvfzq2bikvcrOgIPRtu42MzIPYZP16kokKktlZk69aW779pk8jf/y5y7pzI6tUi/fuL/Oc/InFxTq9qs9z+Fdez4Tbunbhel/2WLROZPt2+fT/6SAvXunXaEGvWLJHFi0WeTB3SndsHRM+Gyx7EOUwmkfBw7XFamsj+/bbv6+cn8re/iaxcKXLnjsiKFdrxtmzRp65Pc/tXnEMs19c4IP/6l/a8JZKSRCIjtXAEB4v89a/aBT/g/Lo+ze1fcQ6xXJ/JJPLyy1qDLi3VHrdEp07a9ceePSKPHol88onI3r0iHh66VLdp2foXoS8OsVxbTY02NAoP135WVzf0Ji3x9tvahbqPj4jBoA3ToqK0T8YuX9auS/Tg9q94a/UgDIh9SkvvyPDhRdKzp0VKS2vF318kLMy+Y3k99ZlrbKzIP//peB1V3P4Vb61rEA6x7FNSckZOn35DQkI8paTk/yQwsKcYDM45dny8SH6+SGWlc47XHLcPiJ4Nlz2I40wmk7z85KLDZDJJuD3jK4Wnv6F3Nrd/xRs33MrKSomPj5fc3FynH5sBsc+VK1d0DYgj39Dbwu1f8cb/8NPDw0MGDx4sCQkJMmHCBCkpKXHo2FOmTJGDBw+KCIdY9mocisa9ib0uXRKpqtK+oU9M1H63dav2KZce3DYgVqtVNm/eLCkpKVJVVSVTp06VBw8eSFpampw7d05qamokJiZGlixZIpV2DlJ9fHykS5cucuzYMfn666/l6tWrsmPHDiefSYPbt29LamqqrFy5Um7fvq1bOY8fP5a8vDzZt2+fbmXUKS4ulpCQEBERGT9+vIwbN87uY5lMIu++K5KR4aTK2aL1byB2XH5+PmJjYxEcHIy0tDScOXMGY8aMgb+/P1JTU1FTUwMAyMnJQXR0NHr16oXMzMwWl9N4mm5ycjKWLVsGf39/jB492qmzDGtqavDZZ58hMDAQgwYNwqBBgxAcHIy1Nk5Hboldu3bh1VdfRffu3eHn54f3338f5x2cwNacixcvYsKECejevTt8fX0xc+ZMh8q5c0ebO2I0apOtWot7BeTCBeyYM6d+hl9ZWVmTP2dlZeGVV15BZGQkvv/+ewANS/4EBARg1KhROHv27HOLedb0XUALzeTJk+Ht7Y1Vy5YBDi5JlL1jB/r27Yvw8HBs27YNVqsVVqu1fjZkdHQ0du/e7VAZAFBYWIiJEyfCYDDUL6Wkx4zJioqK+inOo0ePxk8//YQDBw7AaDSiU6dOMBqNOHjwYIuOWVUF/O53wLBhQGWlw1VsEfcIyN27wKJFgMGAqsREFBYWPnPTqqqq+hfIaDTi0qVLALTFHJ631lbdWll1IVNN0927dy8KJ00CQkOBzZsBq7Vl53T0KPD73+PLuDh8+umnePjw4a82qZtPbzAYYDQacfny5ZaVgaaLXRiNRly8ePFX2/z444947bXXEBYWhszMTFhbei5omOL84osvIjo6GtnZ2b/a5vTp00hMTETv3pEYMeIxdu7U5tM9zyefaGt8OPheZBfXDojZrM1v79FD61+f9Aq2uHDhAoxGI/z8/Jos+1PXGDZt2tRk+/z8fAwbNqx+2FY3TFOyWIDMTKBbN21SdX7+8/cpLQVmzAC8vICJE4GSkufu8ssvv7R4SaK6njMoKAiDBw/Gvn37bNo+MDAQb731Fo4cOfL8c3kiJyenyfplzxsWXrlSg0WLtCXSoqK0l1h1SmVlwPXrNlfHqVo/IDt3au+4AGAyaaufPGsVlGvXtLW0Nm7UFn+wQ05ODmJiYppch5jN5vpF6EpKSup7lhkzZuDmzZstL+TWLeBPf9JWHTCZnr3dtWuAvz8wciTQaNhmK1uXJGpusTxbXb9+vcmySbdu3XrmtnXDNntXwCwv19YSDAsDwsOBmprmF3lorsm0FtcIiGoVFDtWU3xa4+uQkSNHoqCgAOXl5UhJSYGPjw9Gjx6NgoICh8vBlSt1BTYfeKBhTRs7NV6S6OkPC06cOIF33nkHnTt3btJr2uPYsWOIjY1FSEgI0tPT8bjRG9TTw7aioiKHzunRI+DAAe1xc4s8dLyAvPsuMHOmtlTF7NmttgqKyWTChx9+CG9vb3Tr1g0DBgxATk6O08tRBt5JiouL8cEHH8DHxwdz585FYmIivLy8kJycXL/esaPqPizo0aMH3njjDeTl5bVo2GaP5hZ5aK7JtBbX6EFacRUUAJg5cyaGDRvW5F3RqVop8IC2JFFCQgLGjh2LEydO6FLG3bt3MWfOHPTu3Ru9evXCli1b7LqQt0Vza2G1ZQ/iGnPSP/5YZMECkSNHRO7d03UVFBGRl156SUpLS/X7Zvy3vxU5cUIkOlqbG3rzpjbTRwfx8fESHx+vy7HrBAcHy+effy6rV68WAOLr66treSL630JiKw+gNeZluZbU1FQ5deqUZGVl6VOA2awF3tNTC3xyssioUfqURbpyjR6klVmtVn3vq2rFZY9IX257L5YjeGcu2apDthKLxcKAkE06ZCvRfYhF7UaHDQh7ELJFh2wlHGKRrTpkK+EQi2zVYQPCHoRs0SFbCYdYZKsO2Uo4xCJbddiAsAchW3S4VlJeXi6XLl2SHj16tHVVyA10mICYzWZZt26dREZGyp07d2T27NltXSVyAx3iZsXc3FxZuHCh3LhxQ5YvXy5z5szhNQjZpF33IIWFhWI0GiUhIUFGjRolFy9elPnz5zMcZLN2GZCysjKZP3++9O/fXzw8PKSwsFAyMjKkS5cubV01cjPtKiC1tbWSkZEhERERkp+fL3l5eZKdnS19+vRp66qRm2o31yDZ2dmyYMECqa2tlbVr10pSUpJ4tMb/6KJ2ze0DcvXqVZk0aZIUFBTI0qVLZcGCBeLn59fW1aJ2wu0Dsn79evH19ZXz589LaGhoW1eH2hm3vwYpLi6WgQMHMhykC7cPCO+rIj25fUB4Zy7pye1bFnsQ0lO7CAh7ENKL27csDrFIT27fstiDkJ7cvmXx3zOTntw+IOxBSE9u37IYENKT27csDrFIT24fEPYgpCe3b1nsQUhPbh8Q9iCkJ7f/F2zXrl0TX19fCQkJaeuqUDvk9gEh0hPHJkQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQKDAiRAgNCpMCAECkwIEQK/w+cGgzrZirynAAAAABJRU5ErkJggg==" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Selective leukotriene D4 (LTD4) receptor antagonist; PPARα and PPARγ agonist.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. Selective leukotriene D4 (LTD4) receptor antagonist; PPARα and PPARγ agonist.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">anti-asthmatic drug</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.sigmaaldrich.com/catalog/product/sigma/l5408?lang=en&region=US>http://www.sigmaaldrich.com/catalog/product/sigma/l5408?lang=en&region=US</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">3969</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/3969>https://pubchem.ncbi.nlm.nih.gov/compound/3969</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">12</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 L1000FWD</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K77554836</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">triamcinolone</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C21H27FO6</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Inhibitor of  phospholipase A2 on cell membranes, nuclear factor kappa-B</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Triamcinolone is a corticosteroid with anti-inflammatory properties.8 These properties are used to treat inflammation in conditions that affect various organs and tissues. Triamcinolone should not be administered as an epidural injection.\nCorticosteroids like triamcinolone inhibit phospholipase A2 on cell membranes, preventing the breakdown of lysosomal membranes of leukocytes, which in turn prevent the formation of arachidonic acid, which decrease expression of cyclooxygenase and lipoxygenase, inhibiting synthesis of prostaglandins and leukotrienes. Anti-inflammatory activity occurs via reversal of vascular dilation and reducing permeability, which prevents macrophage and leukocyte migration. Triamcinolone also inhibits nuclear factor kappa-B, which decreases the production of pro-inflammatory signals such as interleukin-6, interleukin-8, and monocyte chemoattractant protein-1</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">corticosteroid-responsive dermatoses</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Triamcinolone>http://en.wikipedia.org/wiki/Triamcinolone</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">31307</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/31307>https://pubchem.ncbi.nlm.nih.gov/compound/31307</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00620>https://go.drugbank.com/drugs/DB00620</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">23</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 L1000FWD</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K78126613</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">menadione</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C11H8O2</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Menadione (vitamin K3) is involved as a cofactor in the posttranslational gamma-carboxylation of glutamic acid residues of certain proteins in the body. These proteins include the vitamin K-dependent coagulation factors II (prothrombin), VII (proconvertin), IX (Christmas factor), X (Stuart factor), protein C, protein S, protein Zv and a growth-arrest-specific factor (Gas6). In contrast to the other vitamin K-dependent proteins in the blood coagulation cascade, protein C and protein S serve anticoagulant roles. The two vitamin K-dependent proteins found in bone are osteocalcin, also known as bone G1a (gamma-carboxyglutamate) protein or BGP, and the matrix G1a protein or MGP. Gamma-carboxylation is catalyzed by the vitamin K-dependent gamma-carboxylases. The reduced form of vitamin K, vitamin K hydroquinone, is the actual cofactor for the gamma-carboxylases. Proteins containing gamma-carboxyglutamate are called G1a proteins.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">EGFR Inhibitor-associated Rash</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Menadione>http://en.wikipedia.org/wiki/Menadione</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">4055</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/4055>https://pubchem.ncbi.nlm.nih.gov/compound/4055</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00170>https://go.drugbank.com/drugs/DB00170</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">9</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 TopoCMap</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K78431006</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Crizotinib</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C21H22Cl2FN5O</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Crizotinib is a tyrosine kinase receptor inhibitor (anaplastic lymphoma kinase, hepatocyte growth factor receptor and Recepteur d'Origine Nantais)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Crizotinib is a tyrosine kinase receptor inhibitor. More specifically, it inhibits anaplastic lymphoma kinase (ALK), hepatocyte growth factor receptor (HGFR, c-MET), and Recepteur d'Origine Nantais (RON). Abnormalities in the ALK gene caused by mutations or translocations may lead to expression of oncogenic fusion proteins. In patients with NSCLC, they have the EML4-ALK gene. Crizotinib inhibits ALK tyrosine kinase which ultimately results in decreased proliferation of cells that carry the genetic mutation and tumour survivability. \nPF-2341066 (Crizotinib) is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nnM, respectivley. \nPF-2341066 (Crizotinib) is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nnM, respectivley.PF-2341066 (Crizotinib) is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nnM, respectivley.\n</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Crizotinib is used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic-lymphoma kinase (ALK)-positive as detected by a FDA-approved test.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Crizotinib,http://www.selleckchem.com/products/PF-2341066.html>http://en.wikipedia.org/wiki/Crizotinib,http://www.selleckchem.com/products/PF-2341066.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">11626560</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/11626560>https://pubchem.ncbi.nlm.nih.gov/compound/11626560</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB08865>https://go.drugbank.com/drugs/DB08865</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">27.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved; In top 10 iLINCS</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K78599730</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">manumycin-a</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C31H38N2O7</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">An antibiotic that acts as a selective and vigorous inhibitor of Ras farnesyltransferase</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Manumycin A is an antibiotic originally generated by Streptomyces parvulus that acts as a selective and vigorous inhibitor of Ras farnesyltransferase. The compound has been observed to block the activity of IKKβ by robustly and rapidly inhibiting TNF alpha induced phosphorylation of IκBα and NF-κB nuclear translocation. Studies indicate that Manumycin A has the ability to induce the dimerization of IKKβ and dissociation of IKK from IKKγ/NEMO, the adapter protein. Atherosclerosis studies report that Manumycin A decreases oxidative stress. Additionally, Manumycin A irreversibly inhibits neutral sphingomyelina, and has been shown to produce nitric oxide and induce apoptosis in leukemia cell studies. Manumycin A is an inhibitor of Farnesyl Transferase and N-SMase.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.scbt.com/datasheet-200857-manumycin-a.html>http://www.scbt.com/datasheet-200857-manumycin-a.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">44483259</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/44483259>https://pubchem.ncbi.nlm.nih.gov/compound/44483259</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">8</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 TopoCMap</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K80527266</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Triacsin C</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C11H19N3O</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">inhibitor of long fatty acyl CoA synthetase</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Triacsin C is an inhibitor of long fatty acyl CoA synthetase that has been isolated from Streptomyces aureofaciens. It blocks β-cell apoptosis, induced by fatty acids (lipoapoptosis) in a rat model of obesity. In addition, it blocks the de novo synthesis of triglycerides, diglycerides, and cholesterol esters, thus interfering with lipid metabolism.\n\nIn addition, triacsin C is a vasodilator.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Triacsin_C>http://en.wikipedia.org/wiki/Triacsin_C</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">73707378</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/73707378>https://pubchem.ncbi.nlm.nih.gov/compound/73707378</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">50.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K81418486</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">vorinostat</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C14H20N2O3</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Vorinostat is a histone deacetylase (HDAC) inhibitor</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Vorinostat inhibits the enzymatic activity of histone deacetylases HDAC1, HDAC2 and HDAC3 (Class I) and HDAC6 (Class II) at nanomolar concentrations (IC50&lt; 86 nM). These enzymes catalyze the removal of acetyl groups from the lysine residues of histones proteins. In some cancer cells, there is an overexpression of HDACs, or an aberrant recruitment of HDACs to oncogenic transcription factors causing hypoacetylation of core nucleosomal histones. By inhibiting histone deacetylase, vorinostat causes the accumulation of acetylated histones and induces cell cycle arrest and/or apoptosis of some transformed cells. The mechanism of the antineoplastic effect of vorinostat has not been fully characterized.\n\n</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used for the treatment of cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Vorinostat,http://www.selleckchem.com/products/Vorinostat-(SAHA).html>http://en.wikipedia.org/wiki/Vorinostat,http://www.selleckchem.com/products/Vorinostat-(SAHA).html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">5311</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/5311>https://pubchem.ncbi.nlm.nih.gov/compound/5311</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB02546>https://go.drugbank.com/drugs/DB02546</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">TopoCMap</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">26; 30; 35; 36</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 TopoCMap</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K89046952</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Cyclacillin</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C15H23N3O4S</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">bactericidal activity \n( inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs))</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">bactericidal activity \n( inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs))</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">\nFor the treatment of bacterial infections caused by susceptible organisms.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Ciclacillin>http://en.wikipedia.org/wiki/Ciclacillin</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">19003</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/19003>https://pubchem.ncbi.nlm.nih.gov/compound/19003</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB01000>https://go.drugbank.com/drugs/DB01000</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">24.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved; In top 10 iLINCS</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K89375097</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Pirenzepine</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C19H21N5O2</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">acetylcholine receptor antagonist; muscarinic receptor antagonist</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Pirenzepine belongs to a group of medications called antispasmodics/anticholinergics. These medications are used to relieve cramps or spasms of the stomach, intestines, and bladder. Pirenzepine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.\nPirenzepine is a muscarinic receptor antagonist and binds to the muscarinic acetylcholine receptor. The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">\nFor the treatment of peptic ulcer, gastric ulcer, and duodenal ulcer.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Pirenzepine>http://en.wikipedia.org/wiki/Pirenzepine</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">185248</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/185248>https://pubchem.ncbi.nlm.nih.gov/compound/185248</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00670>https://go.drugbank.com/drugs/DB00670</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">48.0</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K89839824</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Raltitrexed</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C21H22N4O6S</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">thymidylate synthase inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Raltitrexed belongs to a group of medicines known as antimetabolites. It is used to treat cancer of the colon and rectum. It may also be used to treat other kinds of cancer, as determined by your doctor. Raltitrexed blocks an enzyme needed by the cell to live. This interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by raltitrexed, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern.\n\nRaltitrexed is an antineoplastic Agents and folic acid antagonists. Raltitrexed inhibits thymidylate synthase (TS) leading to DNA fragmentation and cell death. It is transported into cells via a reduced folate carrier. Inside the cell Raltitrexed is extensively polyglutamated, which enhances thymidylate synthase inhibitory power and duration. Inhibition of this enzyme results in decreased synthesis of thymidine triphosphate which is required for DNA synthesis.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">For the treatment of malignant neoplasm of colon and rectum</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Raltitrexed,http://www.selleckchem.com/products/Raltitrexed.html>http://en.wikipedia.org/wiki/Raltitrexed,http://www.selleckchem.com/products/Raltitrexed.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">104758</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/104758>https://pubchem.ncbi.nlm.nih.gov/compound/104758</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00293>https://go.drugbank.com/drugs/DB00293</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">45.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K90864987</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">cobalt(II)-chloride</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Cl2Co</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">CoCl2, a Mimic of Hypoxia, Induces Formation of Polyploid Giant Cells with Stem Characteristics; HSP inducer</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Treatment of HCT-116 and Caco-2 colon cancer cells with the hypoxia mimic CoCl2 induced the formation of cells with larger cell and nuclear size (PGCCs), while the cells with normal morphology were selectively eliminated. Cytometric analysis showed that CoCl2 treatment induced G2 cell cycle arrest and the generation of a polyploid cell subpopulation with increased cellular DNA content. Polyploidy of hypoxia-induced PGCCs was confirmed by FISH analysis. Furthermore, CoCl2 treatment effectively induced the stabilization of HIF-1α, the differential expression of a truncated form of p53 (p47) and decreased levels of cyclin D1, indicating molecular mechanisms associated with cell cycle arrest at G2. Generation of PGCCs also contributed to expansion of a cell subpopulation with cancer stem cells (CSCs) characteristics, as indicated by colonosphere formation assays, and enhanced chemoresistance to 5-fluorouracil and oxaliplatin. In conclusion, the pharmacological induction of hypoxia in colon cancer cells causes the formation of PGCCs, the expansion of a cell subpopulation with CSC characteristics and chemoresistance. The molecular mechanisms involved, including the stabilization of HIF-1 α, the involvement of p53/p47 isoform and cell cycle arrest at G2, suggest novel targets to prevent tumor relapse and treatment failure in colon cancer.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">experimental</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/24288>https://pubchem.ncbi.nlm.nih.gov/compound/24288</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">24288</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/24288>https://pubchem.ncbi.nlm.nih.gov/compound/24288</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS; CLUE</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">1 (iLINCS); 6 (CLUE)</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster 1 and UMAP cluster 2; In PCA cluster; Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K92723993</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Imatinib</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C29H31N7O</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMgAAADICAYAAACtWK6eAAAbFklEQVR4nO3de1RVZd4H8O8BPIASl7yAoigmwsEoZwpFUdO8RKajaUenEbF0ROt12ftaDuUqqTWT4XRTR0uYLoKXCB1UFK0MMy94tyJFUFBTwAuSKIjcDt/3jzMQJGwF9uZw6vdZy7W4nd9+Tp3vs2/Pfh4dSUIIUS8bSzdAiNZMAiKEAgmIEAokIEIokIAIoUACIoQCCYgQCiQgQiiQgAihQAIihAIJiBAKJCBCKJCACKFAAiKEAgmIEAokIEIokIAIoUACIoQCCYgQCiQgQiiQgAihQAIihAIJiBAKJCBCKJCACKFAAiKEAgmIEAokIEIokIAIoUACIoQCCYgQCiQgQiiQgAihQAIihAIJiBAKJCBCKJCACKFAAiKEAgmIEAokIEIokIAIoUACIoQCCYgQCiQgQiiQgAihQAIihAIJiBAKJCBCKJCACKFAAiKEAgmIEAokIEIokIAIoUACIoQCCcjvhMlksnQTrJIE5DeuqqoKr776KoYOHYqHH34YS5cuRUFBgaWbZTV0JGnpRghtFBcXY+rUqdi7dy9WrFiBs2fPIiYmBnl5eRg7diymTp2K0aNHw9bW1tJNbbUkIL9R2dnZGDduHOzs7LBp0yb06NEDgHmPkpqaitWrV2Pt2rVwc3PDlClTEB4ejp49e1q20a2QHGL9Bn311VcIDAxEnz59kJqaCjs7OwwbNgxpaWmwsbHBoEGDEB0djdzcXLz22mvYu3cvfHx8MGjQIMTExODmzZuWfgutB8VvSnR0NPV6PSMjI1lVVcXU1FR27tyZISEhvHbtWoOv+/HHHzlv3jx26tSJrq6unD17NtPS0lqu4a2UBOQ3orS0lM8++yzvuecebtq0iSS5Zs0aOjo6cu7cuaysrLyrOuXl5dy4cSNDQkL4yCOPsKioSMtmt3oSkN+A3Nxc9u/fn7169eKJEydYWVnJiIgIOjg4MDY2tkk1y8rKaGdnx8OHD6vcWusi5yBW7tixYwgKCoKrqysOHToEDw8PhISEYM2aNdi9ezfCwsIaVe/999/HK6+8Ar1ej549eyI9PV2jllsHCYgV27hxI4KDg/HnP/8ZycnJyMnJQWBgIEpKSnDkyBEEBgY2qe7u3bsBAAaDASdPnlSzyVZHAmLF1q5di9mzZ+Of//wnvvjiCwwaNAjDhw/HN998Aw8PjybVNBgMNXsNCYgExKpVVlbC0dERAJCRkYFFixYhJiYGer2+yTUNBgMKCwtx6dIlCQgAO0s3QDRd7d7+xRdfVKWml5cXnJyccPLkSfj7++PMmTMoKyuDvb29KvWtjexBrJgWPbxOp4Ovry/S09Ph5+cHk8mE06dPq7oNayIBsWIGg6Gmh1e77smTJ+Hk5IRu3br9rg+zJCBWzGC4H4GB55CVpVO57i97ptqHcVooLS3F+fPnUVFRodk2mkMCYsWcnByRk+OJ9PSmn5TX59cB0WoPkpubiyFDhiAkJARdu3bFiy++iBMnTmiyraaSgFg5gwFQ+/Pr7++Pixcv4tq1a5oFZP/+/QgMDMS9996LnTt3Yvny5Th16hQefPDBVvXcigTEymkRkPvuuw/29vbIyMiAwWDAqVOnVH0ice3atRg+fDiMRiOSk5Ph7OyMUaNGYcuWLTh37hyMRiP+9a9/wdPTE5MmTcKWLVss90Skpce6iOZZuZJ88EH16544cYKlpaW8dOkSATAhIaHZNWuPEVu1alXNzz/++GM6OjoyNDSUKSkpNJlMNJlM3LNnD8PDw9muXTt6enoyIiKCWVlZzW5HY0hArFxWFtnE8Yh3lJ+fz2HDhrFnz55s06YNDQYDFy9ezLy8vEbXKigo4IgRI+jp6cmDBw/W+d2vw9C1a1dGREQwOzubJFlYWMiVK1eyf//+1Ol0HDZsGA8dOqTKe7wTCYgV27iR7N2bLC8nz54lX3xRvdppaWn09vZmcHAwL168yJ9//pnR0dH8wx/+QBsbG44YMYIJCQksKyu7Y62MjAz6+vpy4MCBvHjxouLfFhYWMjY2liNGjKCNjQ2Dg4MZHR3N4uJikuY927Rp0xgQEMCqqipV3qsSCYgV27iRDAsjly+vPyB79pCnTze+7pYtW+js7Mzw8PB6A3D8+HFGRESwQ4cOdHNzY3h4OI8dO1Zvra1bt9LFxYWhoaG8detWo9px/Pjxmoe4XFxcOGvWLBYUFPDChQsEwJycnMa/uUaSgFixjRvJ1avJKVPIH3+8PSDTppE6HTlkCLlqFVlcrNzjVlVVMSoqinq9nlFRUXfcfmlpKRMSEjhmzBja2trS39+fUVFRzM/Pb3QtJeXl5dy0aROnTJnC8vJykqSLiwu/+uqrZtW9GxIQK1YdkKNHyWef/SUgFy6QN2+av87MJCMjyR49qujj04dGo5E7duy47fCkqKiIEyZMYPv27ZmSktLotvz0009844032LNnTzo4OHDw4MHs0KEDd+7c2bw32YB+/fpx6dKlmtSuTS7z/gb88Y9A7RvRr70GdO4MzJwJXL0KvP46cPo08f77i1FVVYUnnngCDzzwQM3d6+zsbAwYMABZWVk4fPgwHn300Ua3wcvLCwsXLkRWVha2bduGH3/8Ee+99x769euHmJgYlJaWqvRuzVpspLHmERQtrqKCTEoin3ySbNOG9PMjV6xIqrn6lJ+fz82bN5Mkv/32W3bs2JFGo7HmRFgN1T38zZs3aWNjw++//1612iT5wQff8+mnf1C1Zn1kD9ICli1bhueeew4rVqzAtWvXNN+enR0wdiyQmAjk5ADh4cSnn/4DXl5eGDt2LHbv3o2QkBDExMRg5MiRmD59OuLj49GuXTvV2lDdw7dt2xZeXl6q9/Zduz6Ir79+QNWa9dI8gr9jJSUlnDJlCl1dXTlz5sya4/PJkyfziy++oMlkatH2HD58mM8//zzd3Nzo7u5OZ2dnJiUlabKtqKgoPvLIIyTJxx9/nAsXLlS1/unTJEDm56ta9jYSEI3k5OSwX79+9PHxYXp6es3Pjxw5wvDwcDo5ObFLly6MiIjg6aZci22GW7ducf/+/U264Xe3kpKS2KlTJ5LkG2/E8n//V90gVlaSjo7k7t2qlr2NBEQDqamp9PDwqDNZ2+bNm7lw4cKau8PXr1+vuSGm0+n40EMPMTo6+jczD1VWVgnd3SuZn09+9BF5//3qb+OBB8joaPXr1iYBoXk2wjFjxnDEiBGMjY1lSUlJk2utXr2aDg4Ot03WlpyczAEDBlCn03Ho0KGMjY3lzf9ei83IyGBkZCS7d+9OR0fHBi/FWpPKStLBwXyzct8+Uq83XzxQ0+bN5vs/WvpdB6SioqJm8NyiRYs4Z84c3nvvvWzfvj3nzp3L7777rkm1lCZrqw6Dl5cXnZ2dOXXq1JowVFRUcMuWLZwwYQLbtGnDd999V4V3aTkBAWRMDHntmvl8ITNTvdpaDrOp7XcbkKtXr/LRRx9l165d68weWFpayqSkJBqNRtrZ2dXcHb5y5UqDtQoKCjh8+HB6enre9SA6k8nEHTt20Gg0Uq/X09fXl5GRkTx37hxJMi4uju7u7s17kxY2eTL5f/9n/nrUKPLIEfVq32mYjVqsJiCVlZWqHZ9//z35yCM/8rHHnlD84Ofm5jIqKoo+Pj60t7fnmDFjmJCQwIpaxwppaWns2bPnXQ3Ea8iVK1f43nvvMSAggG5ubiwrK+OpU6cIgFevXm1Szdbg9dfJkBBtat9pmI1arCIg8fHx9PX1pZOTE6dPn849e/Y0+fh8/XqyXTsyPJy8i4GoJM1jlL799ltOmzatZjj2ggULGBMTQ2dnZ86cOfOuRrXejfPnz5M0dwj29vbcu3evKnUtISdHncOqqiry+vW6P2tomI3aWnVAag94W7p0Kbdu3cqnnnqKer2evXv35tKlibzbAZ1VVWRUlPlksTlDeEpKSpiQkMBhw4bR29ub77zzTtOL3cH999/Pf//735rV15Ja5whFReYRAePH315/9Wrz16Ghv8OA3Lhxg+PHj2eHDh34zTff1Pldfn4+lyxZwsmT02lrSz7+OJmQQJaWNlzPZDKPblXrunntHv7ixYucPXt2nUMvNUyaNInz5s1TtWZLUeMcITvbfHn4gQfIM2fIW7fIf/xD+f+z2lrlUJOsrCwEBQXh3LlzOHLkCIYOHVrn9x06dMALL7yA+HgDDh0CevUCZs8GunQBdu0CNm0CfH3NA/jOnQNeegmwsQFWrQIGD1anjba2tvDx8cHJkydhb2+PlStX4uzZs+oU/y9rn/pz5Ehg/36guLjxr01JScGcOZtgMACpqYC9PTB0KBAbC1y+rHpTG9TqAvLll1+iX79+CAgIwL59+9C9e3fFv//jH4Fly4C8PGDlSiAgwPzzoCAgJkbbtvr7++PkyZNwc3ODu7u76h9mreekagnz5gHvvffL9ykpwJ0maly2bBlGjx6NgQOP4/PPgVOngAEDABcX4OBBwMtL2zbX1qoCEhMTgz/96U+YO3cuPvvsM7Rt2/auX2tvDxiNQPv25u+b03vdLa0nWDMYDDh//jyKtXgTFRXAnDnACy8AYWHmXa8Gfj0U/+OPzXv3IUPMe/Rfv7W4uDi8+uqrWL9+PV599VWsXh2H8PBrMBqBbdsANzdNmtmwljuaa1hpaSmfeeaZOsuHNUdLXeGIj49n9+7dSZLPPfccw8LCVK1fWlpKW1tbHlHzBkK16GgyLs78dWUlOXy4+ttoQGYm+fLLZJcu5D33kHPm/K3mymRZWRkzMzNZWVnJefPm0cHBgWvWNH9Glaay+B4kLy8PQ4YMwb59+3Dw4EGMGzdOtdq/7r3UVruH1+J8wd7eHt7e3tqchxw/DlQvsGNrC7i7Ay0wFB8AevcG3noLOH8eWL/+Bi5dOoPhw4fD19cX7777LqqqqjB+/HjEx8dj165dmDLF2CLtqpfFoknzNf/OnTtz9OjRLCwsVL1+SYl5L6KVW7du0dbWlkePHuWOHTvo5OSk+vipsWPHcsGCBarWJEl++CG5Zo35a5OpRfcg9bl69SqXLl3Kvn37snPnzuzbt6+mo43vlkX3IMnJyejRoweSkpLg4uKiev1Tp8ydpFbLfjs4OMDb2xvp6ekwGAwoLi5Gbm5us+tWVFQgLy8PwC8XAlSxYoW52waAGTPMl4fmzgWeeQZYsECdbTRR+/btMXfuXHz33Xfw9/fHuHHj0LlzZ4u2CbDwAjouLi64dOkSbG1tNanv6wvodEBmpvlwSwvVh1ahoaFwcXFBeno6unbt2uR6+fn5MBqNaNu2LbZt2wY/Pz8kJiaCJHS6Js7iXloKzJplvv7t72++DNSmjTkwrVBAQAAyMzMt3QwAFr6K5e/vj59++gk3NeriHRyAHj3Un7u2tto9vJ+fX7N6+7S0NPTv3x+VlZX49NNPcePGDaxbtw7l5eXo3bs33nzzTeTk5DSuaF6e+QZCaqr53+DB5stHZJPbqbXWdP/HogHx9fWFTqfTtLfQYnLnuvXVWSpgw4YNGDhwIEaOHImdO3eiqKgIAwcOxJUrV5CUlIT58+dj+/bt6N69O0aOHIm4uDiUlJQo1jxw4ACenzQJlR4ewOHDgIcHEBICLFwIXLzYpHa2BIPBgMzMTMtNWF2bpU+C7rvvPq6pPlnUwMsvV/CZZ7Q72Tt48CDt7OxYWlrK/fv3c3cjx7L8erwZSX755Zd0c3Pj5MmTax6qqlY9q2HHjh3p6urK8PBw7tmz57a6a9eupaOjI8PDw81DYDIySF9fcuBAsomjjltKfv5V9u07jFlZlh/JbPGAhIcf4d//rt1/iE8++YQGg0Gz+tevX6dOp+PWrVsb/dqioiI++eSTdSZYi46Opl6vZ2RkpOIVsbKysnqfW7l8+TIXLFhAR0fHmo4nMTGRe0eNIv/617sfwmxhHTuSW7ZYuhWtICB/+xs5YYJ29Q8cOMA2bdqoNhy9Pm+++SZ1Oh2Dg4P50Ucf8caNG3d8TVZWFu+//34++OCDPHv2LEtLS/nss8826WZpTk4OFy1axN69e1Ov1zM4OJhr1qxhVVUVX3/9der1eq5Yvrypb88ihgwhFy+2dCtaQUA+/ZTUsIOv6eFPnDih3UZovqcTFRVFb29vOjg4KD5XnpGRwXvvvZeTJk3izZs3mZuby/79+7NXr17NamdVVRX37NlDo9HIwMBATpgwQdPpP7U0axb5zDOWbkUrCMiBA+bZ/7Tc83t6enLDhg3abaCW6kdpp06dyrZt27Jbt26MiIjgmTNn6vzNZ599xqqqKh49epTdunXjY489xp9//lmVNly5coUAOGvWrDrbtSZLlpD9+1u6Fa0gINevm2cgrzV1lOr69evHxRbYX1+7do3R0dEMDg6us9ZF9Yn3bSfSKurQoUOTzotai507zYdZlmbxgJDkhg2kSp1nHeXl5Xz++efZrl07/vTTT+pvoBF++OEHvvDCCzVraowePbrOibTaBg8ezLfffluT2r8nFg+IVtO3NDRriaWVlZVxw4YNXL58uabtCg8P5/Tp0zWrr6X6PhMbN5rPV0nz8g7/8z8t0xaLDjWpVv1w0xNPqFMvLS0N48ePR5cuXXDkyBG4u7urU1gFer0eEydO1Hw7/fq9gJQU9SajbmlqfyaayuLD3QF1H25av359nTvSrSkcLalrV38kJ3dvzSNKFNX3mYiNNT9a/corLdeOVhEQoO6jmcXF5pERjUESixcvRmhoKBYtWoTo6Gjo9Xr1G2olDAbgxo1WPaLkjn79uO60aebHqt96q+Xa0CoOsYC6Dzelppp3rX5+wPTpwJQpQKdODb+2uLgYYWFh2LNnD7744gsMGzasZRrdinXrBtxzj3kcWpculm7N3SkrA8rLf/le6wfe7krLnOrUlZlJvvGG8t/k5ZnvpPr5me+TzJmTzaSkpNsuh2ZlZbFPnz41d6TFLwIDyWXLtKt/6dIlHj58mNd/PatbE+TlkUFB5HPPqdAwFbV4QLZvJ11dyb/85e5n+963j3z55TV0dnamh4cH58+fz/T0dO7atYsdO3asuSMt6lq3jtRqYsbU1FR27tyZPj4+bNeuHcPCwrhr164mPVF57Bjp5WWev1eLy/3N0aIBiY42z2wYGWme6bCxbt68ydjYWA4dOpQ6nY7u7u5ctGiRVS8ToBUtL5WuWbOGjo6OnDt3LsvLy+84ckDJ559foYODuX21VotoNVokICUlJZw5cz79/Mq5bZs6NbOzs2sWpxG3q29mw+YGpLKysmaJh1WrVpEk8/LyauYTLiwsVBw58Ota8+bNY/v23bluXQtOldhImgfkwoULfPjhh+nn58eMjFNab078V32zn2/cSA4dah4IGBrauIAUFBRwxIgR9PT05MGDB2t+/s4779DGxoaPPfYY4+PjeevWLZLkiRMnGBERwU6dOtHFxaXOcysFBQUcOXIku3TpwgMHDqj4rtWnaUCqj1NrL0UmWkZ9c4M1dQ+SkZFBX1/fBpd4UApDWVkZ//Of/3DMmDG0s7Njnz592L17dw4YMKBVzFpyJ5reB0lMTERYWBiSk5Ph6uqq5aZEA5p7qTQ5ORn9+/dHYGAgUlJS4OHhcdvf+Pv7IyoqChcuXMDq1atx7do1PProo+jTpw/ef/99DBo0CFu2bMH58+cRFBQEk8mEb775plXMWnJHlk6osLy0tNsvmtR+FDgqKqrRNXNzc/nWW2/R19eXer2eEydOZElJCX/44QfqdDqrWaxUAvI7V1Rknv6zZ09y6dKdPHfuHIuKijhx4kS2b9+eX3/9dbO3sXfvXkZGRpLUeDpVDehIax2tI9RSWAjExwObNz+Jr75Kgr+/P3Q6HTZv3gxvb2/Vt+fj44PIyEiEhoaqXlttrWYslrAcV1fzIMDt2zfi0KFDOHnyJD744AN4eXnh+PHjULsPbU3zXt2JBETU8dBDD8Hb2xvnzp3D5cuXERAQ0PjJ6u5A1elUNSYBEbep7uG7dOkCNzc3TRYGkoAIq1X7A+zr66vJwkBZWVkoKytTta4WJCDiNmpNp9oQPz8/mEwmZGdnq1pXCxIQcRt/f/+aHl6LgDg7O8PT09MqDrMkIOI2tXt4rRYStZYFSiUg4ja1e3h/f38UFBQgPz9f1W1Yy4m6BETUq7qH79GjB9q2bavKhzkxMRHz58+vqS8BEVar+gNsY2MDHx+fZn2Y+d8JNZ5++ml06NABAFBeXo4bN27g3XffxeXLl9VqtuokIKJetXv45tzYKy4uxlNPPYW3334b27dvR0REBJYsWYL58+cjODgYn3zyCbp164Zx48Zh8+bNqLD4LA11SUBEvQwGAzIyMmAymTBgwIAmTaF05swZDBgwAFlZWTh8+DCCg4MxY8YMLFy4EJ9//jni4uJw4sQJ7N+/Hz169MCMGTPg7u6OWbNm4fvvv1f/TTWFZcdKitaqeob47OzsJr3+22+/ZadOnWg0GllcXMzc3FwGBQWxV69ePH78eL2vuXXrFhMSEjhmzBja2tryoYce4pIlS3j1quVWmpKAiAaNHTuWQUFBjIuLa9SsMdWrZEVERNBkMvHYsWP08vLiqFGj7nqJhwsXLjAqKor33Xcf7e3taTQamZSUxMoWntlBAiIadObMGb700kt0d3eveZR2//79Df59aWkpZ8yYQScnJyYmJpIk161b16wlHkwmE1NSUhgaGkpHR0euWLGiye+nKSQg4o4qKyu5Y8cOGo1GtmnThr6+voyMjLxtSYmcnBwGBwfz+PHjdWZA+bT6QfhmKiwsvKvl7dQkARGN8vPPPzM6Opp9+/alra0tR4wYwYSEhDprQF6/fp1jxoyxillL7kSeKBRNdvToUcTFxWHt2rWoqqqC0WjE448/jldeeQWurq5ITEy0jokZFEhARLOVlZUhKSkJcXFxuHr1KgwGAz788EPY29tbumnNJgERqjKZTLC1tbV0M1QjARFCgdxJF0KBBEQIBRIQIRRIQIRQIAERQoEERAgFEhAhFEhAhFAgARFCgQRECAUSECEUSECEUCABEUKBBEQIBRIQIRRIQIRQIAERQoEERAgFEhAhFEhAhFAgARFCgQRECAUSECEUSECEUCABEUKBBEQIBRIQIRRIQIRQIAERQoEERAgFEhAhFEhAhFAgARFCgQRECAUSECEUSECEUCABEUKBBEQIBRIQIRRIQIRQIAERQoEERAgFEhAhFEhAhFAgARFCgQRECAUSECEUSECEUCABEUKBBEQIBRIQIRRIQIRQIAERQoEERAgF/w+LVdB3aGr2ZwAAAABJRU5ErkJggg==" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">A protein-tyrosine kinase inhibitor (inhibits the Bcr-Abl tyrosine kinase), the constitutive abnormal tyrosine kinase created by the Philadelphia chromosome abnormality</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Imatinib mesylate is a protein-tyrosine kinase inhibitor that inhibits the Bcr-Abl tyrosine kinase, the constitutive abnormal tyrosine kinase created by the Philadelphia chromosome abnormality in chronic myeloid leukemia (CML). It inhibits proliferation and induces apoptosis in Bcr-Abl positive cell lines as as well as fresh leukemic cells from Philadelphia chromosome positive chronic myeloid leukemia. In colony formation assays using ex vivo peripheral blood and bone marrow samples, imatinib shows inhibition of Bcr-Abl positive colonies from CML patients.In vivo, it inhibits tumor growth of Bcr-Abl transfected murine myeloid cells as well as Bcr-Abl positive leukemia lines derived from CML patients in blast crisis.\nImatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 &amp;#956;M, 0.1 &amp;#956;M and 0.1 &amp;#956;M, respectively.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST).</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Imatinib,http://www.selleckchem.com/products/Imatinib-Mesylate.html>http://en.wikipedia.org/wiki/Imatinib,http://www.selleckchem.com/products/Imatinib-Mesylate.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">123596</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/123596>https://pubchem.ncbi.nlm.nih.gov/compound/123596</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB00619>https://go.drugbank.com/drugs/DB00619</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">29.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster; FDA approved</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K92991072</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">PAC-1</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C23H28N4O2</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">caspase activator</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">PAC-1 has been used in trials studying the treatment of Lymphoma, Melanoma, Solid Tumors, Breast Cancer, and Thoracic Cancers, among others.\nPAC-1 is a potent procaspase-3 activator with EC50 of 0.22 μM.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">used in trials studying the treatment of Lymphoma, Melanoma, Solid Tumors, Breast Cancer, and Thoracic Cancers, among others.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.selleckchem.com/products/pac-1.html>http://www.selleckchem.com/products/pac-1.html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">6851947</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/6851947>https://pubchem.ncbi.nlm.nih.gov/compound/6851947</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB13048>https://go.drugbank.com/drugs/DB13048</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">21</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 L1000FWD</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K94325918</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">kinetin-riboside</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C15H17N5O5</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMgAAADICAYAAACtWK6eAAAUZUlEQVR4nO3de1TUZf4H8LdyS1CEMQTMiAAvsaInzdU6GnbM1dI1y8bdbpq2622LVnND7Wy4ayquXdguq2hmZHlateTo/jbNtEzzUuiqYJmL4p31khSgMMDw/v3xFdTCJ2C+A2nv1zmeMzPMfL7PON/3fG/P80wTkoSI1KhpYzdA5KdMARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQMFRMRAARExUEBEDBQQEQPfxm6A1E5BQQGys7ORk5MDkhg6dCgiIiIau1lXvSYk2diN+DnKzASSk4GcHODYMeDVV4HnnwdcLuDLL63Hs7OBoqLd+Ne/BuLo0aNo1qwZ4uPj4ePjg5CQEKxZs6ax38ZVT7tYjahnT2D+/Av3n38eaN4c6N4dmD4dOHAAiI2NRFpaGvbt24eioiJkZWXhn//8JzZs2ID169c3XuO9oKysDMXFxY3djEtoC9JIMjOB4mJg9Wpg8mTgzTeB8eOBggIgPh5o1uzCc48cOYKcnBzs3r0bOTk5mD59Ol588UVs3boV27ZtQ5MmTbzb2PJyYMIEwMfHauCoUUCfPrYv5plnnoHL5cLzzz9ve+36avBjkIqKCsybNw+bNm1CXFwc4uLi0K5dO9wUFwdHePgPX9BAH05jmTgRePFFwOEAYmKst7twIbB794XdrICAe1BefgidO3dGp06dQBJ//vOfERsbi8zMTNx7773ebeSiRUCPHsAjjwBuN9C/v62fwY4dOzB79mykpaUhPj4ekZGRmDhxoveDXxtsYBkZGQwJCWFSUhIHDx7Mm266iQEBAfy/xESyRQvy5ptJp5OcMoXcto1MTyffest6cUUF2bdvQzfZK1asIBcvtm4//DD51FPW7cpKsndvcsQIcs4ccs0a8vjxghpr/O1v77B//xxWVHi5sU88QX711YX7Dz5Injnjcdlz586xrKyMZWVljIuL48cff0yn00l/f38mJibyq4uX2UgaNCAVFRXs0KEDZ86cecnjbrebJYcOkR99RM6bR06aRA4ZQi5b5rUPp7GVl5N5eaTbXf8ahYVk69bkG2/Y1qyazZ1Lvv22ddvtvvAlVVFx6WdTR8OHD+crr7xCklyyZAl79uzJgoICOp1ODhs2jAEBAZyWkkKWlnr4BuqvQQOyZMkStmzZkgUFBVy1ahV/85vf/PiLLvfhXOFyckjAWsk9MWcOGRXl5XWorIwcP976snrkEXLdOuvxDRtIHx9ri79zZ61KVVRUcMuWLSTJnTt3MjIyksXFxXS73Xz77bdZcdHm8N///jefHTKEbN+eXL/e9rdVGw0WkMrKSiYkJHDatGkkyV/+8pf805/+9OMvvNyHc4XLzCQjIz2vU1JCXn89+dJLntf6gU2byE8+MT9n1y4rID4+5D338MSOHcanf/PNNwwLC+O+fftIksuWLWNxcfHlX3DuHJmSQvr7W8s5ebKOb8IzDRaQ5cuXMzg4mGfOnOEHH3zAa665hsePH2+oxf/kzJljHWvYYcEC8t577alVbds2MjiY/Otfa/f8PXtYPnIkI4ODedddd3Hz5s2X/PnTTz/lhg0bSFpbhjp/9jt3kj16kL/4hWf7pXXUYAHp1q0bn3nmGZJkr169+OSTT9a9yHvvkRMm2NuwRjJ2LDlqlD21bF9fdu4kHQ7yj3+s80v37dvHRx99lH5+fuzbty+zsrJIkps3b+aePXs8a5fbTX79tXW7rIz8wx/IpCRrz+Ljj63HV6wgFy2ybh85Yj3HAw0SkJUrVzIoKIgnT57kunXrGBAQwKNHj9a90LvvkjfcYHv7GkO/fm7OmGFfvRUrrF31sjLr4P+pp8iDBw8yLy+vTnX25eTwbFQU+fjjHrXnwIEDHDJkCAcPHuxRncu63NlNmwPSIFfSn3vuOYwfPx5hYWGYPn06Ro0aheuuu67uhRISgMOHgW+/tb2NDe3AgQ7o0GGVrTW/f2V+/vz5WLx4Me6///5aXaH++uuvcfudd2LeAw8AL7/sUVtuvPFG3HnnncjPz/eozmXl5FhdDgDrGll4uHWdDAAyMoCxY4EpUzxejNcDsnr1auzevRsTJkzAli1b8Nlnn+Hpp5+uX7H27QF/f6uz0hXM5XLh4ME8xMS0tbVuv37Ali3WFXoAyM3NxbXXXosPP/wQzZs3x6lTp/Dggw/W+NrDhw+jf//+6NevH/44cyZgw0W63NxcxMXFeVynRvHxwPbt1u3KSuDECSA01Lo/YgQwbx4wa5bHi/F6QGbMmIExY8YgMjIS06ZNw4gRIxAdHV2/Yr6+QMeO1rfHFezAgQNwu92IjY21vXbVlXnAWkEBVK+k+/btQ15eHgBg27ZtmHL+G/bEiRNITExEjx49sGjRIjRtas9qkZubi3bt2tlS6wceewzYvBlISgIefRSYOtUri/FqV5P169fjiy++wLvvvovPP/8c69atw1dffeVRzWX9+6Pg6FGMtqmNjSE3Nxfh4eEIDg62vXbXrlZ3FQAIDAxEdHQ07rrrLgBAixYtMHLkSABA69atcfvttwMA8vPz4Xa7sWDBAvj4+NjWltzcXDidTtvqXcLPD3jttR8+PmTIhdtt21rdpD3h0RHMj+jTpw/Hjx9Pkhw0aBCHDx/ucc3Zs2czMTHR4zo1qelA1+ZjPpLktGnT2LVrV4/ruN3km296fhbL5XIxJiaGs2fP9rhNVdxuNwMCAvjZZ5/ZVrMxeG0XiySaNm0KPz8/AMATTzyBZ5991uO6CQkJyM7O9rjO5Xz/QNdOFRUVmDVrFmbNmoW9e/eiV69eWL16db1qkcC4cdaYkuPHPWuXv78/UlJSMGvWLJw5c8azYucdOnQILpfLe7tYDcWb6du0aRODg4M5adIkj+oUFxdzxowZzMrK4pEjRwiAx44ds6mVF1R1IHzoITI7+8IWpE8fcswYq1Nhfbcgubm57N27N8PDw7lixQqeOHGCycnJDAwMZJcuXbh06VJWVlbWut6kSWRICPkjF65rze12s0uXLpw6daot9T788EMGBwfbUqsxef06SFZWFlu1asWxY8fSXcd9AZfLxVdffZURERGMjY3luvPdTBwOB1evXm17W6sCsn07OXKkPbtYbreb6enpDAwMpNPp5OnTp1laWlrdveLkyZNMSUlhy5YtmZCQwIyMjEv6I9Vk+vRTDAmx2mmnzMxMNmvWrH7XqL7nH//4B7t162ZDqxpXg1wo/M9//sOwsDD+7ne/q1VIKisruXTpUsbFxTEsLIypqaksLS2ly+Vieno6o6Ki2L59+1qtTLVRWkp+913NXdA9Ccj+/fuZmJjI1q1b87333iNJbt++nQkJCXz66acvee7p06eZkpLCkJAQxsfHMyMjg+Xl5T+omZKSwoiIWH7+uXd6J9522238gw0HWhMnTqxdZ9SfuAbravLll1+yTZs2fOCBB2r84KusXbuWN998M1u0aMHk5GQWFhayoqKCCxcuZFRUFK+//nq+/PLLfPbZZxkaGsqOHTvyrbfeMtY0+eILq3tPXXq+mPrWkVbA09PTGRQURKfTyVOnTrG8vJypqakMCAjg6NGjWXiZbryFhYVMTU2lw+HgjTfeyPT09Or39sILLzAwMJAfV3Wr8IJPP/2Ufn5+zM3N9ajO4MGDq7sWXckatLv73r172bZtWw4bNoxlZWWX/G3Lli3s06cPAwMDmZSUxJPne22uXbuWnTt3psPhYGpqKs+dO1f9mqKiIqalpTEiIoLR0dFMS0tjaS37fZeVkampZEAAOXo0WVRUu/dQWkq2aWN1/6lpKEReXh7vuOMOhoaG8q3zXSGys7PZrVs3RkZGctWqVbVaTmFhIWfNmsWwsDDGxMTwkUceYbNmzfjRRx/VrqEeGDBgAB966CGPasTHx3NR1ab3CtbgIwrz8vIYExPDgQMHsqSkhCQ5efJk+vn5ccyYMdUH35s2bWLv3r0ZFBTE5ORkFhQUXLZmcXEx09LS2KZNG0ZFRTEtLa26dk127NjBAQP2Mjq6fr3nt20jBw0ib7ihjA888CCzs7OrtxrNmzfnwIEDeezYsUu2Gk6nk2fqMdCruLiYL7zwAuPi4jhv3ry6N7Yedu3aRV9fX+6o5xkAt9vNZs2acePGjTa3rOE1eEBI8tChQ4yLi+OAAQN47tw57tq1q3p8wO7du+l0Ounn58fRo0czPz+/1nVLS0uZnp7Otm3bMjw8nKmpqTx79mz138vKyjht2jT6+/szOXmOx4OVdu3K43333UcfHx/26NGDDoeDb58f3LVnzx52796dERERzMzMrFf9NWvWVG8xwsLC+MEHH3jW4Dr47W9/y4EDB9b5dYcPH2ZGRgYB1Omz+6lqlICQZH5+Pjt16sTExEQWFhZy7969dDqd9PHxodPp9Ggf2OVyMSMjg7GxsQwLC2NKSgq3bt3KW265hZGRkVy5cqWN78Ta2gHg1q1bazxrVV/jxo3jY489RpLs0KED33nnHbua/KMOHDhAf3//yx7vFBQUcOPGjZw7dy7HjRvH3r17MyQkhADocDg4ceJE7qzlKMOfskYLCEn+73//Y0JCAjt37kxfX18OHjyY2dnZttV3uVxcsGABY2Ji2KlTJ44cOZLffvutbfWruN1uNm3alNu3b2d5eTl//etf13urcbGpU6fyvvvuI0n27Nmzevx2Qxk7dixvu+025uTkcOnSpUxJSaHT6WR8fDybNGlCPz8/xsfH0+l0MiUlhStXruT+/ftZWVnJyspKDhgwgKNHj/bK/3lDadSAkNbpzWXLlv1gBJqdysvLL3vWyC4hISFcu3atrTXnzJnDPn36kCTvvvtu/rW2o/tscuzYMd56660EwMjISA4aNIjJycnMyMhgVlbWj54QycvLY/PmzRkREcGMjIw6XQj9qWj0uXlbtWqF+++/36vL8PX1RYsWLby6DIfDYVs3jSoREfFwOA4DADp1ehBNm15ra/0fU1FRgfHjx2Pt2rUICgqq8+ujo6Mxffp0TJgwASNGjMDrr7+O1157DQkJCV5orXdo6lGbOBwOFFQN2LFJUNDd+OILa+BSSclD+O9/+9ta38TlcmHo0KG45ZZb6hWOKklJSejZsycAYOPGjejatSueeuoplJSU2NVUr1JAbNKx44coKXnY1poOB1C1Ubr4dkNISkrC8ePH0bFjR4/qNG3aFIsWLcI111wDwNoqnT59GgEBAXY00+sUEJuUl4fi+PH6f9PWxOEAzp61ZnwPDb0wotTblixZgvnz56Nv37621OvYsSOmnh/QNHToUCxcuNC2QVne1ujHIFcLb3zDt2pljfkpKmq4LUhOTg5+//vfAwDuuOMO2+pOnjwZJSUl+Mtf/gJfX9/Lz7mcmWnNOfDoo8DRo0BqqueDnjyggNgkNBTYu9femm3aAEeOWLejo4EuXeyt/31FRUUYNmwYzp07B8DegPj5+WHmzJkXHvDyhNh2UUBsEhrq3W/43r2tf95CEqNGjaoeEh0XF1f/uQNqIyfH+r0HoOZZSbZutfYvW7b0Xhtq4crYEbwCDBgAPPmkd2pnZgIdOlh7JQcPApMm2b+M999/H8uXL6++b+fWo0YNNCuJpxQQG2RmAkOHAgMHem8F9uZQYMA6eN64cSMGDRoEALYdoF9WA81K4intYtmkagUeONA79fv1s36NKjHRO/UBoFevXujVqxe2bNmC9u3be29BQMPNSuIhbUFs8v1J26qUl1u7X4sXAxUVni3j4jmv6iwz0/qdN8A6O/T441bjHn/c2jccPhz45BMAwK233opWrVp51tirhAJio5pWYLfbOrieONGa827RogqUV01cZXDwIOB0AqdOXXjs4jmvbFF1Junvf7duP/ecjcWvDgqIjS5egQsLrTOXH31k7V7n5QFjxgDLl7+Fdu3aYe7cuXC5XD+oQQLp6UDnzkBZmXV/yBDg4fMX6Rcvtn4Nt16+P2etaX5bsTR2b8mrVUGBNelDUJD1s4vvv2/9/uDZs2f50ksvsU2bNrzuuuuqZ2ohySNHSvirX1nT+WRk2NygmmafuEp/vctO2oJ4SUiI9U2fl2cdg4wYAQwb9i+sWrUKSUlJ2L9/P6ZMmYKYmBgAwBtvvIGbb45DePh3yMmxDgm87go5k9SoGjuhPxfffEOmps5lSEjIJTOx5Ofn85577mFwcDDT09OvyDETV7MmJNnYIf05KSwsxCuvvIK0tDQEBQXhu+++Q/fu3fH6668jKiqqsZsn36OANJLi4mKsWLECDocDd999N5rY8HscYj8FRMRAB+kiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgYKCAiBgqIiIECImKggIgY/D/756Oa0jo6IQAAAABJRU5ErkJggg==" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Kinetin riboside is an anti-proliferative agent which induces apoptosis in certain cell lines. Mechanistic studies show that Kinetin riboside upregulates CDKN1A, causes depletion of ATP, and causes a cell cycle arrest at the G2/M phase. Further studies suggest that Kinetin riboside also disrupts the mitochondrial membrane potential, induces the release of cytochrome c, activates caspase-3, upregulates Bad and down-regulates Bcl-2.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://www.scbt.com/datasheet-221789-kinetin-riboside.html>http://www.scbt.com/datasheet-221789-kinetin-riboside.html</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">20345</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/20345>https://pubchem.ncbi.nlm.nih.gov/compound/20345</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD; TopoCMap</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">17 (L1000FWD); 5 (TopoCMap)</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Found by 2 tools</td>
    </tr>
    <tr>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K98548675</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">parthenolide</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C15H20O3</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">NFkB pathway inhibitor</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Parthenolide ((-)-Parthenolide) is a sesquiterpene lactone which occurs naturally in the plant feverfew(Tanacetum parthenium) and also promotes the ubiquitination of MDM2 and activates p53 cellular functions.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">Parthenolide has been used in trials studying the diagnostic of Allergic Contact Dermatitis.</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=http://en.wikipedia.org/wiki/Parthenolide,http://www.selleckchem.com/products/Parthenolide((-)-Parthenolide).html>http://en.wikipedia.org/wiki/Parthenolide,http://www.selleckchem.com/products/Parthenolide((-)-Parthenolide).html</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">6473881</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/6473881>https://pubchem.ncbi.nlm.nih.gov/compound/6473881</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://go.drugbank.com/drugs/DB13063>https://go.drugbank.com/drugs/DB13063</a></td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">+</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">L1000FWD</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">26</td>
      <td style = "background-color: #D9E1F2;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In top 10 L1000FWD</td>
    </tr>
    <tr>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">BRD-K98762074</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">HG6-64-1</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">C32H34F3N5O2</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><img data-content="rdkit/molecule" src="data:image/png;base64,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" alt="Mol"/></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">selective B-Raf (Serine/threonine-protein kinase B-raf) inhibitor</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">HG6-64-1 is a potent and selective B-Raf inhibitor extracted from patent WO 2011090738 A2, example 9 (XI-1); has a IC50 of 0.09 μM on B-raf V600E transformed Ba/F3 cells.</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">53302361</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"><a href=https://pubchem.ncbi.nlm.nih.gov/compound/53302361>https://pubchem.ncbi.nlm.nih.gov/compound/53302361</a></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px"></td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">iLINCS</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">32.0</td>
      <td style = "background-color: #FFFFFF;font-family: Century Gothic;font-size: medium;text-align: center;padding: 0px 20px 0px 0px">In PCA cluster</td>
    </tr>
  </tbody>
</table></p>